{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:19:13Z","timestamp":1788049153538,"version":"build-2784847793"},"reference-count":944,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.ijtb.2022.06.004","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T02:00:23Z","timestamp":1657504823000},"page":"S1-S191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"S1","title":["Indian Guidelines on Nebulization Therapy"],"prefix":"10.1016","volume":"69","author":[{"given":"S.K.","family":"Katiyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.N.","family":"Gaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.N.","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Sarangdhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.C.","family":"Khilnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruva","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupak","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaiz A.","family":"Koul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok A.","family":"Mahashur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Ghoshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Behera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Talwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiman","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Paramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.B.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Kumar T","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.D.","family":"Motiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randeep","family":"Guleria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Luhadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.K.","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.K.","family":"Vijayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Faye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Murar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunachalam","family":"M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Janmeja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Prajapat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debajyoti","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inderpaul Singh","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.K.","family":"Samaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jogesh","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra K.","family":"Bainara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilkanth T.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanta R.","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Mrigpuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Vijai","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Swarnakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Katiyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Spalgais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhadeep","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya","family":"Kant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Hadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visweswaran","family":"B","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib1","first-page":"357","article-title":"The bronchodilator effects of terbutaline: route of administration and patterns of response","volume":"37","author":"Dulfano","year":"1976","journal-title":"Ann Allergy"},{"key":"10.1016\/j.ijtb.2022.06.004_bib2","doi-asserted-by":"crossref","unstructured":"Martin AR, Finlay WH. Nebulizers for drug delivery to the lungs. Expert Opin Drug Deliv; 12(6):889-900.","DOI":"10.1517\/17425247.2015.995087"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1378\/chest.127.1.335","article-title":"American College of Chest Physicians; American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians\/American College of Asthma, Allergy, and Immunology","volume":"127","author":"Dolovich","year":"2005","journal-title":"Ches"},{"key":"10.1016\/j.ijtb.2022.06.004_bib4","series-title":"A guide to aerosol delivery devices for respiratory therapists","author":"Hess","year":"2005"},{"key":"10.1016\/j.ijtb.2022.06.004_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/rmed.2001.1292","article-title":"Survey of patients' views of domiciliary nebuliser treatment for chronic lung disease","volume":"96","author":"Barta","year":"2002","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib6","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1164\/rccm.2504001","article-title":"Statement on home care for patients with respiratory disorders","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03259089","article-title":"Delivery devices for inhaled asthma medication","volume":"6","author":"Selroos","year":"1996","journal-title":"Clin Immunother"},{"key":"10.1016\/j.ijtb.2022.06.004_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1008786600530","article-title":"A review of the technical aspects of drug nebulization","volume":"22","author":"Le Brun","year":"2000","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.ijtb.2022.06.004_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1378\/chest.110.2.498","article-title":"Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand","volume":"110","author":"Hess","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib10","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1089\/jam.1998.11.Suppl_1.S-73","article-title":"A review of issues relating to nebulizer standards","volume":"11","author":"Dennis","year":"1998","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib11","first-page":"1406","article-title":"Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol","volume":"47","author":"Dhand","year":"2002","journal-title":"Respir Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/17425247.2.2.377","article-title":"The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems","volume":"2","author":"Knoch","year":"2005","journal-title":"Expert Opin Drug Deliver"},{"issue":"Suppl 2","key":"10.1016\/j.ijtb.2022.06.004_bib13","first-page":"S4","article-title":"Nebulizer therapy. Guidelines. British Thoracic Society Nebulizer Project Group","volume":"52","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib14","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/09031936.00166410","article-title":"What the pulmonary specialist should know about the new inhalational therapies","volume":"37","author":"Laube","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/thx.45.10.728","article-title":"Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output","volume":"45","author":"Dennis","year":"1990","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/adc.68.4.441","article-title":"How to get drugs into the respiratory tract","volume":"68","author":"O\u2019Callaghan","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ijtb.2022.06.004_bib17","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1183\/09031936.95.08071214","article-title":"Comparison of 23 nebuliser\/compressor combinations for domiciliary use","volume":"8","author":"Smith","year":"1995","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/08958378.2011.632787","article-title":"Regional particle size dependent deposition of inhaled aerosols in rats and mice","volume":"24","author":"Kuehl","year":"2012","journal-title":"Inhalation Toxicology"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/jam.2005.18.225","article-title":"In\u00a0Vitro Determination of the Optimal Particle Size for Nebulized Aerosol Delivery to Infants","volume":"18","author":"Sch\u00fcepp","year":"2005","journal-title":"Journal of Aerosol Medicine"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/thx.41.5.364","article-title":"Effect of aerosol particle size on bronchodilation with nebulised terbutaline in asthmatic subjects","volume":"41","author":"Clay","year":"1986","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/thx.42.3.190","article-title":"Effect of nebulised aerosol size on lung deposition in patients with mild asthma","volume":"42","author":"Clay","year":"1987","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/thx.42.6.457","article-title":"Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma","volume":"42","author":"Mitchell","year":"1987","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-5173(94)90436-7","article-title":"The optimal particle size for beta-adrenergic aerosols in mild asthmatics","volume":"107","author":"Zanen","year":"1994","journal-title":"International Journal of Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib24","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1152\/japplphysiol.00525.2003","article-title":"Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols","volume":"95","author":"Usmani","year":"2003","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib25","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1164\/rccm.200410-1414OC","article-title":"Regional Lung Deposition and Bronchodilator Response as a Function of 2-Agonist Particle Size","volume":"172","author":"Usmani","year":"2005","journal-title":"Am J Repir Crit Care Med"},{"issue":"8350","key":"10.1016\/j.ijtb.2022.06.004_bib26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(83)90679-7","article-title":"Assessment of jet nebulisers for lung aerosol therapy","volume":"2","author":"Clay","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.ijtb.2022.06.004_bib27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1378\/chest.104.4.1114","article-title":"Optimal duration of nebulized albuterol therapy","volume":"104","author":"Malone","year":"1993","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib28","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1378\/chest.111.5.1206","article-title":"The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols","volume":"111","author":"Coates","year":"1997","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/089426802760292618","article-title":"Improving Drug Delivery from Medical Nebulizers: The Effects of Increased Nebulizer Flow Rates and Reservoirs","volume":"15","author":"Corcoran","year":"2002","journal-title":"Journal of Aerosol Medicine"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib30","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1081-1206(10)62906-7","article-title":"Characterization of aerosol output from various nebulizer\/compressor combinations","volume":"86","author":"Reisner","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1185\/03007990802708236","article-title":"In\u00a0vitro deposition properties of nebulized formoterol fumarate: effect of nebulization time, airflow, volume of fill and nebulizer type","volume":"25","author":"Akapo","year":"2009","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.ijtb.2022.06.004_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/jam.1997.10.331","article-title":"Nebulized gentamicin in children with cystic fibrosis: Enhancing antibiotic lung deposition by increasing flow rate and fill volume","volume":"10","author":"Mallol","year":"1997","journal-title":"Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung"},{"key":"10.1016\/j.ijtb.2022.06.004_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5152\/ejp.2014.00087","article-title":"Jet, ultrasonic, and mesh nebulizers: an evaluation of nebulizers for better clinical outcomes","volume":"16","author":"Ari","year":"2014","journal-title":"Eurasian Journal of Pulmonology"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib34","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1378\/chest.109.3.814","article-title":"Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. National Association for Medical Direction of Respiratory Care (NAMDRC) Consensus Group","volume":"109","author":"O'Donohue","year":"1996","journal-title":"Chest"},{"issue":"9770","key":"10.1016\/j.ijtb.2022.06.004_bib35","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(10)60926-9","article-title":"Aerosol drug delivery: developments in device design and clinical use","volume":"377","author":"Dolovich","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib36","first-page":"1703","article-title":"Aerosol delivery of recombinant human DNase I: in\u00a0vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer","volume":"53","author":"Johnson","year":"2008","journal-title":"Respir Care"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib37","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.4187\/respcare.02074","article-title":"Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in\u00a0vitro model","volume":"58","author":"Berlinski","year":"2013","journal-title":"Respir Care"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jamp.2014.1149","article-title":"Performance Comparisons of Jet and Mesh Nebulizers Using Different Interfaces in Simulated Spontaneously Breathing Adults and Children","volume":"28","author":"Ari","year":"2015","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib39","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4187\/respcare.03592","article-title":"Effect of Aerosol Devices and Administration Techniques on Drug Delivery in a Simulated Spontaneously Breathing Pediatric Tracheostomy Model","volume":"60","author":"Alhamad","year":"2015","journal-title":"Respir Care"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4187\/respcare.02490","article-title":"Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in\u00a0vitro pediatric model","volume":"60","author":"Sidler-Moix","year":"2015","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4187\/respcare.00826","article-title":"Testing of nebulizers for delivering magnesium sulfate to pediatric asthma patients in the emergency department","volume":"56","author":"Coates","year":"2011","journal-title":"Respir Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pupt.2018.04.005","article-title":"Modeling and optimization of nebulizers' performance in non-invasive ventilation using different fill volumes: Comparative study between vibrating mesh and jet nebulizers","volume":"50","author":"Saeed","year":"2018","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/jamp.2010.0817","article-title":"Omron NE U22: Comparison between vibrating mesh and jet nebulizer","volume":"23","author":"Skaria","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0928-0987(03)00148-9","article-title":"Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers","volume":"19","author":"Steckel","year":"2003","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/jamp.2010.0816","article-title":"Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations","volume":"23","author":"Pitance","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1378\/chest.123.1.28","article-title":"Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system","volume":"123","author":"Geller","year":"2003","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib47","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/bcp.13988","article-title":"Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover study","volume":"85","author":"van Velzen","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2125.2005.02168.x","article-title":"Dose-response to salbutamol via a novel palm sized nebuliser (Aerodose Inhaler), conventional nebuliser (Pari LC Plus) and metered dose inhaler (Ventolin Evohaler) in moderate to severe asthmatics","volume":"59","author":"Lipworth","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1648652","article-title":"Comparison of the Clinical Efficacy of Salbutamol with Jet and Mesh Nebulizers in Asthmatic Children","volume":"2018","author":"Murayama","year":"2018","journal-title":"Pulm Med"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ajem.2017.10.067","article-title":"Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department","volume":"36","author":"Dunne","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib51","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1097\/PCC.0b013e3182712783","article-title":"Albuterol delivery in an in\u00a0vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers","volume":"14","author":"Sidler-Moix","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib52","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.4187\/respcare.04013","article-title":"Effect of Tidal Volume and Nebulizer Type and Position on Albuterol Delivery in a Pediatric Model of Mechanical Ventilation","volume":"60","author":"Berlinski","year":"2015","journal-title":"Respir Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pupt.2017.12.006","article-title":"Aerosol delivery during spontaneous breathing with different types of nebulizers- in\u00a0vitro\/ex\u00a0vivo models evaluation","volume":"48","author":"Lin","year":"2018","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib54","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ejpb.2014.10.009","article-title":"Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics","volume":"88","author":"Lehofer","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/jam.2006.19.372","article-title":"Rationale for the selection of an aerosol delivery system for gene delivery","volume":"19","author":"Lentz","year":"2006","journal-title":"J Aerosol Med"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib56","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1183\/09031936.00118408","article-title":"Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency","volume":"34","author":"Brand","year":"2009","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib57","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1081-1206(10)62906-7","article-title":"Characterization of aerosol output from various nebulizer\/compressor combinations","volume":"86","author":"Reisner","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib58","first-page":"1671","article-title":"In\u00a0vitro delivery of budesonide from 30 jet nebulizer\/compressor combinations using infant and child breathing patterns","volume":"54","author":"Berg","year":"2009","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib59","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4187\/respcare.05892","article-title":"Crossover Evaluation of Compressors and Nebulizers Typically Used by Cystic Fibrosis Patients","volume":"63","author":"Awad","year":"2018","journal-title":"Respir Care"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib60","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4187\/respcare.02776","article-title":"Longitudinal evaluation of compressor\/nebulizer performance","volume":"59","author":"Awad","year":"2014","journal-title":"Respir Care"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib61","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1517\/17425247.2015.1014339","article-title":"Factors to consider when selecting a nebulizer for a new inhaled drug product development program","volume":"12","author":"Elphick","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ijtb.2022.06.004_bib62","first-page":"17","article-title":"Variability in delivered dose and respirable delivered dose from nebulizers: are current regulatory testing guidelines sufficient to produce meaningful information?","volume":"10","author":"Hatley","year":"2017","journal-title":"Med Devices (Auckl)"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1183\/09031936.01.00220001","article-title":"European Respiratory Society Guidelines on the use of nebulizers","volume":"18","author":"Boe","year":"2001","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jam.1999.12.47","article-title":"The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension","volume":"12","author":"Nikander","year":"1999","journal-title":"J Aerosol Med"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib65","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1378\/chest.111.1.204","article-title":"A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) Respirator Solution","volume":"111","author":"MacNeish","year":"1997","journal-title":"Chest"},{"issue":"1-2","key":"10.1016\/j.ijtb.2022.06.004_bib66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2007.02.035","article-title":"The influence of fluid physicochemical properties on vibrating-mesh nebulization","volume":"339","author":"Ghazanfari","year":"2007","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib67","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1089\/jam.2007.0622","article-title":"Performance of the vibrating membrane aerosol generation device: Aeroneb Micropump Nebulizer","volume":"20","author":"Zhang","year":"2007","journal-title":"J Aerosol Med"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib68","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1378\/chest.111.5.1206","article-title":"The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols","volume":"111","author":"Coates","year":"1997","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib69","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1089\/jam.2006.19.484","article-title":"Nebulized drug admixtures: effect on aerosol characteristics and albuterol output","volume":"19","author":"Berlinski","year":"2006","journal-title":"J Aerosol Med"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib70","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ajhp\/62.8.828","article-title":"Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium","volume":"62","author":"Lee","year":"2005","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib71","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcf.2013.09.006","article-title":"Inhalation solutions--which ones may be mixed? Physico-chemical compatibility of drug solutions in nebulizers--update 2013","volume":"13","author":"Kamin","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2146\/ajhp080261","article-title":"Mixing and compatibility guide for commonly used aerosolized medications","volume":"67","author":"Burchett","year":"2010","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib73","doi-asserted-by":"crossref","first-page":"79","DOI":"10.22270\/jddt.v9i6.3465","article-title":"Nebulized Glycopyrronium and Formoterol, Budesonide aerosol aerodynamic assessment vibrating mesh and compressor air nebulizer: Anderson Cascade Impactor Study","volume":"9","author":"Menon","year":"2019","journal-title":"Journal of Drug Delivery & Therapeutics"},{"key":"10.1016\/j.ijtb.2022.06.004_bib74","series-title":"Delivery of inhaled medication in adults","author":"Hess","year":"2020"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib75","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ppul.1950140309","article-title":"Facemasks versus mouthpieces for aerosol treatment of asthmatic children","volume":"14","author":"Lowenthal","year":"1992","journal-title":"Pediatric Pulmonology"},{"issue":"2 Pt 1","key":"10.1016\/j.ijtb.2022.06.004_bib76","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1164\/ajrccm.162.2.9909030","article-title":"Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma","volume":"162","author":"Mellon","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1081\/JAS-120002291","article-title":"Mouthpiece versus facemask for delivery of nebulized salbutamol in exacerbated childhood asthma","volume":"39","author":"Kishida","year":"2002","journal-title":"J Asthma"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib78","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/thx.48.10.1045","article-title":"Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation","volume":"48","author":"Everard","year":"1993","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib79","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1183\/09031936.94.07122185","article-title":"The influence of age on aerosol deposition in children with cystic fibrosis","volume":"7","author":"Chua","year":"1994","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib80","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ppul.22999","article-title":"Nasal versus oral aerosol delivery to the \"lungs\" in infants and toddlers","volume":"50","author":"Amirav","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib81","first-page":"1021","article-title":"Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model","volume":"52","author":"Lin","year":"2007","journal-title":"Respir Care"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib82","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/ppul.10454","article-title":"Facemasks and facial deposition of aerosols","volume":"37","author":"Sangwan","year":"2004","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl 1","key":"10.1016\/j.ijtb.2022.06.004_bib83","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1089\/jam.2007.0579","article-title":"Facemask design, facial deposition, and delivered dose of nebulized aerosols","volume":"20","author":"Smaldone","year":"2007","journal-title":"J Aerosol Med"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib84","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.07-1827","article-title":"Facial and ocular deposition of nebulized budesonide: effects of face mask design","volume":"133","author":"Harris","year":"2008","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib85","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/02770900009055471","article-title":"Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide","volume":"37","author":"Nikander","year":"2000","journal-title":"J Asthma"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib86","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/jam.2005.18.354","article-title":"Variation in pediatric aerosol delivery: importance of facemask","volume":"18","author":"Smaldone","year":"2005","journal-title":"J Aerosol Med"},{"issue":"Suppl 1","key":"10.1016\/j.ijtb.2022.06.004_bib87","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1089\/jam.2007.0572","article-title":"Facemasks and aerosol delivery in\u00a0vivo","volume":"20","author":"Erzinger","year":"2007","journal-title":"J Aerosol Med"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib88","first-page":"56","article-title":"An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing","volume":"51","author":"Restrepo","year":"2006","journal-title":"Respir Care"},{"issue":"796","key":"10.1016\/j.ijtb.2022.06.004_bib89","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/pgmj.68.796.132","article-title":"Ocular hazards of nebulized bronchodilators","volume":"68","author":"Mulpeter","year":"1992","journal-title":"Postgraduate Medical Journal"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib90","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0002-9394(00)00465-7","article-title":"Acute angle-closure glaucoma after albuterol nebulizer treatment","volume":"130","author":"Rho","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib91","first-page":"268","article-title":"Nebulised ipratropium causing a unilateral fixed dilated pupil in the critically ill patient: a report of two cases","volume":"6","author":"Eustace","year":"2004","journal-title":"Crit Care Resusc"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib92","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4187\/respcare.02978","article-title":"Effect of Mask Dead Space and Occlusion of Mask Holes on Delivery of Nebulized Albuterol","volume":"59","author":"Berlinski","year":"2014","journal-title":"Respiratory Care"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib93","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/0894268041457192","article-title":"Does wearing a noseclip during inhalation improve lung deposition?","volume":"17","author":"Kohler","year":"2004","journal-title":"J Aerosol Med"},{"issue":"33-34","key":"10.1016\/j.ijtb.2022.06.004_bib94","first-page":"495","article-title":"Wearing a noseclip improves nebulised aerosol delivery","volume":"131","author":"Meier","year":"2001","journal-title":"Swiss Med Wkly"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib95","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4187\/respcare.03606","article-title":"In\u00a0Vitro Evaluation of Aerosols Delivered via the Nasal Route","volume":"60","author":"El Taoum","year":"2015","journal-title":"Respir Care"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib96","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1089\/jamp.2013.1069","article-title":"Design of aerosol face masks for children using computerized 3D face analysis","volume":"27","author":"Amirav","year":"2014","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib97","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/archdischild-2011-301236","article-title":"Lung aerosol deposition in suckling infants","volume":"97","author":"Amirav","year":"2012","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/jamp.2007.0662","article-title":"Aerosol delivery through nasal cannulas: an in\u00a0vitro study","volume":"21","author":"Bhashyam","year":"2008","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib99","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ppul.21421","article-title":"In\u00a0vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula","volume":"46","author":"Ari","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib100","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ppul.23123","article-title":"Comparison of HFNC, bubble CPAP and SiPAP on aerosol delivery in neonates: An in-vitro study","volume":"50","author":"Sunbul","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib101","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ppul.23509","article-title":"Nasal high flow nebulization in infants and toddlers: An in\u00a0vitro and in\u00a0vivo scintigraphic study","volume":"52","author":"Reminiac","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib102","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1097\/PCC.0b013e31828a7f79","article-title":"Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system","volume":"14","author":"Perry","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib103","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/adc.88.8.719","article-title":"Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears!","volume":"88","author":"Amirav","year":"2003","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib104","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jpeds.2005.05.035","article-title":"Aerosol delivery in respiratory syncytial virus bronchiolitis: hood or face mask?","volume":"147","author":"Amirav","year":"2005","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.jp.7211434","article-title":"Hood versus mask nebulization in infants with evolving bronchopulmonary dysplasia in the neonatal intensive care unit","volume":"26","author":"Kugelman","year":"2006","journal-title":"J Perinatol"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib106","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/jamp.2013.1051","article-title":"Hood nebulization: effects of head direction and breathing mode on particle inhalability and deposition in a 7-month-old infant model","volume":"27","author":"Kim","year":"2014","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/jamp.2007.0619","article-title":"Numerical investigation of aerosol deposition at the eyes when using a hood inhaler for infants--a 3D simulation","volume":"21","author":"Amirav","year":"2008","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib108","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5409\/wjcp.v5.i3.281","article-title":"Drug delivery interfaces: A way to optimize inhalation therapy in spontaneously breathing children","volume":"5","author":"Ari","year":"2016","journal-title":"World J Clin Pediatr"},{"key":"10.1016\/j.ijtb.2022.06.004_bib109","series-title":"A Guide to Aerosol Delivery Devices for Respiratory Therapists","author":"Gardenhire","year":"2017"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib110","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/0009922808316188","article-title":"Nebulization therapy for asthma: a practical guide for the busy pediatrician","volume":"47","author":"Welch","year":"2008","journal-title":"Clin Pediatr (Phila)"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib111","first-page":"174","article-title":"Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric","volume":"49","author":"Rau","year":"2004","journal-title":"Respir Care"},{"issue":"Suppl 1","key":"10.1016\/j.ijtb.2022.06.004_bib112","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1089\/jam.1998.11.Suppl_1.S-73","article-title":"A review of issues relating to nebulizer standards","volume":"11","author":"Dennis","year":"1998","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib113","series-title":"Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities","author":"Rutala","year":"2008"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib114","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4187\/respcare.03513","article-title":"Device Cleaning and Infection Control in Aerosol Therapy","volume":"60","author":"O\u2019Malley","year":"2015","journal-title":"Respiratory Care"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib115","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1442-200X.2006.02252.x","article-title":"Microbial colonization of nebulizers used by asthmatic children","volume":"48","author":"Cohen","year":"2006","journal-title":"Pediatr Int"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib116","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2214.2006.00669.x","article-title":"Microbial contamination of nebulizers in the home treatment of cystic fibrosis","volume":"33","author":"Blau","year":"2007","journal-title":"Child Care Health Dev"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib117","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0022-3476(87)80069-0","article-title":"Pseudomonas species contamination of cystic fibrosis patients\u2019 home inhalation equipment","volume":"111","author":"Pitchford","year":"1987","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib118","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3476(98)70497-4","article-title":"Home nebulizer use among patients with cystic fibrosis","volume":"132","author":"Rosenfeld","year":"1998","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib119","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1067\/mic.2000.110214","article-title":"Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis","volume":"28","author":"Vassal","year":"2000","journal-title":"Am J Infect Control"},{"issue":"6602","key":"10.1016\/j.ijtb.2022.06.004_bib120","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/bmj.295.6602.812","article-title":"Bacterial contamination of home nebuliser","volume":"295","author":"Barnes","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib121","first-page":"267","article-title":"Transmission of gram-negative bacilli to asthmatic children via home nebulizers","volume":"66","author":"Wexler","year":"1991","journal-title":"Ann Allergy"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib122","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0002-9343(84)90520-5","article-title":"Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols","volume":"77","author":"Craven","year":"1984","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib123","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM197003052821003","article-title":"Fine-particle humidifiers. Source of Pseudomonas aeruginosa infections in a respiratory- disease unit","volume":"282","author":"Grieble","year":"1970","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib124","first-page":"454","article-title":"A hospital outbreak of Klebsiella pneumonia from inhalation therapy with contaminated aerosol solutions","volume":"95","author":"Mertz","year":"1967","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1067\/mic.2000.110214","article-title":"Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis","volume":"28","author":"Vassal","year":"2000","journal-title":"Am J Infect Control"},{"issue":"6602","key":"10.1016\/j.ijtb.2022.06.004_bib126","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/bmj.295.6602.812","article-title":"Bacterial contamination of home nebuliser","volume":"295","author":"Barnes","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib127","first-page":"267","article-title":"Transmission of gram-negative bacilli to asthmatic children via home nebulizers","volume":"66","author":"Wexler","year":"1991","journal-title":"Ann Allergy"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0195-6701(97)90195-X","article-title":"Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients","volume":"36","author":"Jakobsson","year":"1997","journal-title":"J Hosp Infect"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM197003052821003","article-title":"Fine-particle humidifiers. Source of Pseudomonas aeruginosa infections in a respiratory-disease unit","volume":"282","author":"Grieble","year":"1970","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib130","first-page":"454","article-title":"A hospital outbreak of Klebsiella pneumonia from inhalation therapy with contaminated aerosol solutions","volume":"95","author":"Mertz","year":"1967","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib131","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2013-000018","article-title":"Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease","volume":"1","author":"Jarvis","year":"2014","journal-title":"BMJ Open Respir Res"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib132","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1442-200X.2006.02252.x","article-title":"Microbial colonization of nebulizers used by asthmatic children","volume":"48","author":"Cohen","year":"2006","journal-title":"Pediatr Int"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib133","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2214.2006.00669.x","article-title":"Microbial contamination of nebulizers in the home treatment of cystic fibrosis","volume":"33","author":"Blau","year":"2007","journal-title":"Child Care Health Dev"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib134","first-page":"1504","article-title":"Nebulizer use and maintenance by cystic fibrosis patients: A survey study","volume":"49","author":"Lester","year":"2004","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib135a","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1008786600530","article-title":"A review of the technical aspects of drug nebulization","volume":"22","author":"Le Brun","year":"2000","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.ijtb.2022.06.004_bib136","series-title":"Stopping the spread of germs","year":"2009"},{"issue":"RR-3","key":"10.1016\/j.ijtb.2022.06.004_bib137","first-page":"1","article-title":"Guidelines for preventing health care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee","volume":"53","author":"Tablan","year":"2004","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib138","first-page":"1346","article-title":"Determinants of patient adherence to an aerosol regimen","volume":"50","author":"Rau","year":"2005","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib139","first-page":"145","article-title":"Inhaled corticosteroid therapy with nebulized beclomethasone dipropionate","volume":"23","author":"Nicolini","year":"2010","journal-title":"PulmPharmacolTher"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib140","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/thx.54.8.661","article-title":"Nebulised corticosteroids in the treatment of patients with asthma","volume":"54","author":"Hill","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib141","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.5588\/ijtld.12.0005","article-title":"Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH)","volume":"16","author":"Jindal","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib142","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5005\/ijcdas-56-1-5","article-title":"Guidelines for diagnosis and management of chronic obstructive pulmonary disease: joint recommendations of Indian Chest Society and National College of Chest Physicians (India)","volume":"56","author":"Gupta","year":"2014","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"10.1016\/j.ijtb.2022.06.004_bib143","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1183\/09031936.00142414","article-title":"Global and regional trends in COPD mortality, 1990\u20132010","volume":"45","author":"Burney","year":"2015","journal-title":"EurRespir J"},{"issue":"Suppl","key":"10.1016\/j.ijtb.2022.06.004_bib144","first-page":"5","article-title":"India needs a national COPD prevention and control programme","volume":"60","author":"Salvi","year":"2012","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.ijtb.2022.06.004_bib145","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2146\/ajhp100452","article-title":"Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease","volume":"68","author":"Barrons","year":"2011","journal-title":"Am J Health SystPharm"},{"key":"10.1016\/j.ijtb.2022.06.004_bib146","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(10)60926-9","article-title":"Aerosol drug delivery: developments in device design and clinical use","volume":"377","author":"Dolovich","year":"2011","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib147","first-page":"228","article-title":"European Respiratory Society Guidelines on the use of nebulizers: Guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers","volume":"18","author":"Boe","year":"2001","journal-title":"EurRespir J"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib148","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0954-6111(03)00021-0","article-title":"Spacers and nebulisers for the delivery of beta-agonists in non-life-threatening acute asthma","volume":"97","author":"Cates","year":"2003","journal-title":"Respir Med"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib149","first-page":"CD000052","article-title":"Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma","author":"Cates","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0954-6111(96)90201-2","article-title":"Inhalers and nebulizers: which to choose and why","volume":"90","author":"Pedersen","year":"1996","journal-title":"Respir Med"},{"issue":"96","key":"10.1016\/j.ijtb.2022.06.004_bib151","first-page":"117","article-title":"Inhaler choice in primary practice","volume":"14","author":"Chapman","year":"2005","journal-title":"EurRespir Rev"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib152","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1378\/chest.112.6.1501","article-title":"Nebulized wet aerosol treatment in emergency department--is it essential? Comparison with large spacer device for metered-dose inhaler","volume":"112","author":"Mandelberg","year":"1997","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib153","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jhm.2386","article-title":"Nebulized bronchodilators instead of metered-dose inhalers for obstructive pulmonary symptoms","volume":"10","author":"Moriates","year":"2015","journal-title":"J Hosp Med"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib154","first-page":"CD011826","article-title":"Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD","volume":"29","author":"van Geffen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib155","first-page":"1360","article-title":"Problems with inhaler use: a call for improved clinician and patient education","volume":"50","author":"Fink","year":"2005","journal-title":"Respir Care"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib156","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0007-0971(86)90008-2","article-title":"What determines whether an elderly patient can use a metered dose inhaler correctly?","volume":"80","author":"Allen","year":"1986","journal-title":"Br J Dis Chest"},{"issue":"915","key":"10.1016\/j.ijtb.2022.06.004_bib157","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/pmj.78.915.37","article-title":"Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age","volume":"78","author":"Allen","year":"2002","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib158","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/15412555.2011.630047","article-title":"The role of nebulized therapy in the management of COPD: evidence and recommendations","volume":"9","author":"Dhand","year":"2012","journal-title":"COPD"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib159","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/archinte.1996.00440090084008","article-title":"Characteristics predicting incorrect metered-dose inhaler technique in older subjects","volume":"156","author":"Gray","year":"1996","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0954-6111(98)90031-2","article-title":"Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics","volume":"92","author":"Bisgaard","year":"1998","journal-title":"Respir Med"},{"issue":"Suppl B","key":"10.1016\/j.ijtb.2022.06.004_bib161","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0954-6111(03)90074-6","article-title":"Comparison of the Efficacy and Safety of High Doses of Beclomethasone Dipropionate Suspension for Nebulization and Beclomethasone Dipropionate via a Metered-Dose Inhaler in Steroid-Dependent Adults With Moderate to Severe Asthma","volume":"97","author":"Grzelewska-Rzymowska 1","year":"2003","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib162","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1164\/ajrccm.165.5.2109093","article-title":"Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial","volume":"165","author":"Maltais","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib163","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0735-6757(93)90105-K","article-title":"The efficacy and safety of a continuous albuterol protocol for the treatment of acute adult asthma attacks","volume":"11","author":"Olshaker","year":"1993","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib164","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1378\/chest.122.1.160","article-title":"Continuous vs intermittent-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis","volume":"122","author":"Rodrigo","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib165","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1378\/chest.06-2125","article-title":"Continuous bronchodilator therapy","volume":"131","author":"Peters","year":"2007","journal-title":"CHEST"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib166","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/thx.40.3.180","article-title":"Nebulised salbutamol without oxygen in severe acute asthma: how effective and how safe?","volume":"40","author":"Douglas","year":"1985","journal-title":"Thorax"},{"issue":"7304","key":"10.1016\/j.ijtb.2022.06.004_bib167","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/bmj.323.7304.98","article-title":"Oxygen treatment for acute severe asthma","volume":"323","author":"Inwald","year":"2001","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib168","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/adc.63.8.900","article-title":"Air or oxygen as driving gas for nebulised salbutamol","volume":"63","author":"Gleeson","year":"1988","journal-title":"Arch Dis Child"},{"issue":"6413","key":"10.1016\/j.ijtb.2022.06.004_bib169","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bmj.288.6413.272","article-title":"Oxygen as a driving gas for nebulisers: safe or dangerous?","volume":"288","author":"Gunawardena","year":"1984","journal-title":"Br Med J Clin Res Ed"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib170","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/qjmed\/hci084","article-title":"Initial oxygen management in patients with an exacerbation of chronic obstructive pulmonary disease","volume":"98","author":"Durrington","year":"2005","journal-title":"QJM: monthly journal of the Association of Physicians"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib171","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/ajrccm.161.5.9904119","article-title":"The role of hypoventilation and ventilation-perfusion redistribution in oxygen-induced hypercapnia during acute exacerbations of chronic obstructive pulmonary disease","volume":"161","author":"Robinson","year":"2000","journal-title":"American journal of respiratory and critical care medicine"},{"key":"10.1016\/j.ijtb.2022.06.004_bib172","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/imj.13684","article-title":"An audit of change in clinical practice: from oxygen-driven to air-driven nebulisers for prehospital patients with acute exacerbations of chronic obstructive pulmonary disease(AECOPD)","volume":"48","author":"Heys","year":"2018","journal-title":"Internal medicine journal"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib173","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/emermed-2011-200443","article-title":"Randomised controlled crossover trial of the effect on PtCO2 of oxygen-driven versus air-driven nebulisers in severe chronic obstructive pulmonary disease","volume":"29","author":"Edwards","year":"2012","journal-title":"Emergency medicine journal : EMJ."},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib174","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12890-018-0720-7","article-title":"Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial","volume":"18","author":"Bardsley","year":"2018","journal-title":"BMC pulmonary medicine"},{"key":"10.1016\/j.ijtb.2022.06.004_bib175","first-page":"1","article-title":"BTS guidelines for oxygen use in adults in healthcare and emergency settings","volume":"72","year":"2017","journal-title":"Br Thorac Soc"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib176","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1378\/chest.97.3.693","article-title":"Continuous nebulization of albuterol (salbutamol) in acute asthma","volume":"97","author":"Colacone","year":"1990","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib177","first-page":"41","article-title":"Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study","volume":"75","author":"Reisner","year":"1995","journal-title":"Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib178","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1553-2712.1996.tb03346.x","article-title":"Continuous vs intermittent nebulized albuterol for emergency management of asthma","volume":"3","author":"Khine","year":"1996","journal-title":"Academic emergency medicine: official journal of the Society for Academic Emergency Medicine"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib179","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/mem.2000.109169","article-title":"Continuous versus intermittent nebulization of salbutamol in acute severe asthma: a randomized, controlled trial","volume":"36","author":"Besbes-Ouanes","year":"2000","journal-title":"Annals of emergency medicine"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib180","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0196-0644(05)80411-1","article-title":"Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department","volume":"22","author":"Rudnitsky","year":"1993","journal-title":"Annals of emergency medicine"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib181","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0196-0644(05)80412-3","article-title":"Continuous versus intermittent albuterol nebulization in the treatment of acute asthma","volume":"22","author":"Lin","year":"1993","journal-title":"Annals of emergency medicine"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib182","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1378\/chest.122.1.160","article-title":"Continuous vs intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis","volume":"122","author":"Rodrigo","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib183","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001115","article-title":"Continuous versus intermittent beta-agonists for acute asthma","author":"Camargo","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ijtb.2022.06.004_bib184","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2147\/COPD.S114034","article-title":"A review of nebulized drug delivery in COPD","volume":"11","author":"Tashkin","year":"2016","journal-title":"International Journal of COPD"},{"key":"10.1016\/j.ijtb.2022.06.004_bib185","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.2147\/DDDT.S135377","article-title":"Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease","volume":"11","author":"Santus","year":"2017","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.ijtb.2022.06.004_bib186","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1378\/chest.109.3.814","article-title":"National Association for Medical Direction of Respiratory Care (NAMDRC) Consensus Group. Guidelines for the Use of Nebulizers in the Home and at Domiciliary Sites Report of a Consensus Conference","volume":"109","author":"O'Donohue","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib187","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.arbres.2014.05.003","article-title":"Nebulized Therapy. SEPAR Year","volume":"50","author":"Olveira","year":"2014","journal-title":"Arch Bronconeumol"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib188","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s41030-017-0043-5","article-title":"A Review on the Safety and Efficacy of Inhaled Corticosteroids in the Management of Asthma","volume":"3","author":"Qian","year":"2017","journal-title":"Pulmonary Therapy, June"},{"key":"10.1016\/j.ijtb.2022.06.004_bib189","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ccm.2013.10.005","article-title":"Bronchodilators: current and future","volume":"35","author":"Cazzola","year":"2014","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib190","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/jama.1900.24610190014001c","article-title":"The use of adrenal substance in the treatment of asthma","volume":"34","author":"Solis-Cohen","year":"1900","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib191","first-page":"227","article-title":"Nebulised adrenaline in acute severe asthma: comparison with salbutamol","volume":"71","author":"Coupe","year":"1987","journal-title":"Eur J Respir Dis."},{"key":"10.1016\/j.ijtb.2022.06.004_bib192","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajem.2005.10.008","article-title":"Comparison between nebulized adrenaline and b2 agonists for the treatment of acute asthma. A meta-analysis of randomized trials","volume":"24","author":"Rodrigo","year":"2006","journal-title":"American Journal of Emergency Medicine"},{"key":"10.1016\/j.ijtb.2022.06.004_bib193","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1378\/chest.125.3.1081","article-title":"Acute asthma in adults: a review","volume":"125","author":"Rodrigo","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib194","first-page":"12","article-title":"Comparison of Nebulized Adrenaline versus Salbutamol in Wheeze Associated Respiratory Tract Infection in","volume":"39","author":"Som Ray","year":"2002","journal-title":"Infants Indian Pediatrics"},{"key":"10.1016\/j.ijtb.2022.06.004_bib195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF02425149","article-title":"A controlled trial of nebulized salbutamol and adrenaline in acute severe asthma","volume":"21","author":"Abroug","year":"1995","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib196","first-page":"60","article-title":"Consensus Document on Home Nebulization forMaintenance Treatment of Obstructive Airway Diseases: A Joint Initiative by the National Allergy Asthma Bronchitis Institute (NAABI)and Chest Research Foundation (CRF)","volume":"65","author":"Ghoshal","year":"2017","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.ijtb.2022.06.004_bib197","first-page":"68","article-title":"Asthma and COPD preparation, CIMS annual; CIMS medica India pvt","author":"Bhatia","year":"2018","journal-title":"ltm"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib198","first-page":"353","article-title":"Efficacy of nebulized ipratropium in acute bronchial asthma","volume":"3","author":"Aggarwal","year":"2002","journal-title":"Journal, Indian Academy of Clinical Medicine"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib199","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3109\/02770903.2010.517337","article-title":"Levalbuterol versus levalbuterol plus ipratropium in the treatment of severe acute asthma","volume":"47","author":"Cydulka","year":"2010","journal-title":"Journal of Asthma"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1553-2712.1997.tb03715.x","article-title":"Efficacy of atropine sulfate in combination with albuterol in the treatment for acute asthma","volume":"4","author":"Diaz","year":"1997","journal-title":"Academic Emergency Medicine"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib201","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1378\/chest.111.2.311","article-title":"The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group","volume":"111","author":"FitzGerald","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0091-6749(97)70219-7","article-title":"Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma","volume":"100","author":"Garret","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib203","first-page":"345","article-title":"Comparison of salbutamol and ipratropium bromide versus salbutamol alone in the treatment of acute severe asthma","volume":"22","author":"Hossain","year":"2013","journal-title":"Mymensingh Medical Journal"},{"key":"10.1016\/j.ijtb.2022.06.004_bib204","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1378\/chest.110.3.611","article-title":"A comparison of ipratropium and albuterol vs. albuterol alone for the treatment of acute asthma","volume":"110","author":"Karpel","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib205","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0196-0644(98)70308-7","article-title":"Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial","volume":"31","author":"Lin","year":"1998","journal-title":"Ann Emerg Med"},{"issue":"8652","key":"10.1016\/j.ijtb.2022.06.004_bib206","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(89)90126-8","article-title":"Nebulized salbutamol with and without ipratropium bromide in acute airflow obstruction","volume":"1","author":"O\u2019Driscoll","year":"1989","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib207","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1378\/chest.99.5.1084","article-title":"Nebulized atropine sulfate in the treatment of acute asthma","volume":"99","author":"Owens","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib208","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2165\/00003495-198938010-00007","article-title":"Management of Chronic Obstructive Pulmonary Disease","volume":"38","author":"Kesten","year":"1989","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib209","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jemermed.2006.05.025","article-title":"A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma","volume":"31","author":"Salo","year":"2006","journal-title":"Journal of Emergency Medicine"},{"key":"10.1016\/j.ijtb.2022.06.004_bib210","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1378\/chest.97.2.425","article-title":"Nebulized ipratropium in the treatment of acute asthma","volume":"97","author":"Summers","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib211","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1378\/chest.115.4.937","article-title":"Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay Anticholinergics in acute asthma and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial","volume":"115","author":"Weber","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib212","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0196-0644(94)70039-7","article-title":"Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of asthma","volume":"23","author":"Cydulka","year":"1994","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib213","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1378\/chest.94.4.718","article-title":"Should ipratropium be added to beta-agonists in treatment of acute severe asthma?","volume":"94","author":"Higgins","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib214","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.88.1.24","article-title":"Nebulized ipratropium bromide in the treatment of acute asthma","volume":"88","author":"Bryant","year":"1985","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib215","first-page":"102","article-title":"Nebulized salbutamol with and without ipratropium bromide in treatment of acute severe asthma","volume":"22","author":"Inayat","year":"2016","journal-title":"Pak J chest Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib216","article-title":"Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma","volume":"1","author":"Kirkland","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ijtb.2022.06.004_bib217","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/thx.2005.047803","article-title":"Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis","volume":"60","author":"Rodrigo","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib218","series-title":"Global Initiative for Asthma (GINA)","year":"2017"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib219","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4103\/0970-2113.154517","article-title":"Guidelines for diagnosis and management of bronchial asthma: Joint ICS\/NCCP (I) recommendations","volume":"32","author":"Agarwal","year":"2015","journal-title":"Lung India"},{"key":"10.1016\/j.ijtb.2022.06.004_bib220","article-title":"British guideline on the management of asthma","year":"2016","journal-title":"A national clinical guideline"},{"key":"10.1016\/j.ijtb.2022.06.004_bib221","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.2606001","article-title":"(R)-albuterol for asthma (S)-albuterol for asthma: Pro & Con debate","volume":"174","author":"Ameredes","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib222","first-page":"1","article-title":"Albuterol Or Levalbuterol For The Treatment Of Asthma","volume":"3","author":"Pesola","year":"2003","journal-title":"The Internet Journal of Asthma, Allergy and Immunology"},{"issue":"2 Pt 2","key":"10.1016\/j.ijtb.2022.06.004_bib8585a","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0091-6749(99)70277-0","article-title":"Clinical experience with levalbuterol","volume":"104","author":"Nelson","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib8585b","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1378\/chest.129.1.15","article-title":"The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol","volume":"129","author":"Nelson","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib223","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4103\/0253-7613.89817","article-title":"Racemic salbutamol and levosalbutamol in mild persistent asthma: A comparative study of efficacy and safety","volume":"43","author":"Maiti","year":"2011","journal-title":"Indian J Pharmacol"},{"issue":"6 Pt 1","key":"10.1016\/j.ijtb.2022.06.004_bib224","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0091-6749(98)70332-X","article-title":"Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma","volume":"102","author":"Nelson","year":"1998","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib225","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0091-6749(99)70233-2","article-title":"The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients","volume":"103","author":"Gawchik","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib226","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12098-007-0010-5","article-title":"Evidence based review on levosalbutamol","volume":"74","author":"Gupta","year":"2007","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.ijtb.2022.06.004_bib227","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajem.2003.11.001","article-title":"Levalbuterol compared to racemic albuterol in the treatment of acute asthma : result of a pilot study","volume":"22","author":"Nowak","year":"2004","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib228","first-page":"A770","article-title":"Pharmacological properties of S-salbutamol in human airway smooth muscle preparation","volume":"165","author":"Canning","year":"2002","journal-title":"Am J Resp Crit Care Med"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib229","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02772201","article-title":"Comparison of R-, S-, and RS-albuterol interaction with human beta 1- and beta 2-adrenergic receptors","volume":"14","author":"Penn","year":"1996","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2012.11.003","article-title":"Levalbuterol versus albuterol for acute asthma: a systematic review and meta-analysis","volume":"26","author":"Jat","year":"2013","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib231","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4103\/0253-7613.83123","article-title":"A comparative study of efficacy and safety of arformoterol and salbutamol nebulization as rescue therapy in acute non-severe asthma","volume":"43","author":"Das","year":"2011","journal-title":"Ind Jr of Pharmacology"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib232","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0301-0546(08)72549-7","article-title":"Equivalence of a Single Saline Nebulised Dose of Formoterol Powder vs Three Doses of Nebulised Albuterol Every Twenty Minutes in Acute Asthma in Children: A Suitable Cost Effective Approach for Developing Nations","volume":"36","author":"Rodriguez 1","year":"2008","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.ijtb.2022.06.004_bib233","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12890-015-0166-0","article-title":"RELIEF Asia Study investigators. Formoterol as Reliever Medication in Asthma: A Post-Hoc Analysis of the Subgroup of the RELIEF Study in East Asia","volume":"16","author":"Jian Cheng","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib234","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2431-12-21","article-title":"Bronchodilatory Effect of Inhaled Budesonide\/Formoterol and Budesonide\/Salbutamol in Acute Asthma: A Double-Blind, Randomized Controlled Trial","volume":"12","author":"Arun","year":"2012","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1378\/chest.129.1.15","article-title":"The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol","volume":"129","author":"Nelson","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib236","first-page":"135","article-title":"Fenoterol and ipratropium in respiratory treatment of patients with chronic bronchitis","volume":"38","author":"Backman","year":"1985","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib237","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/thx.50.8.834","article-title":"Comparison of nebulized salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease","volume":"50","author":"Moayyedi","year":"1995","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib238","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9343(87)90378-0","article-title":"Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room","volume":"82","author":"Rebuck","year":"1987","journal-title":"The American Journal of Medicine"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib239","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003900","article-title":"Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease","author":"McCrory","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib240","first-page":"CD002984","article-title":"Inhaled short-acting beta2-agonists versus ipratropiumfor acute exacerbations of chronic obstructive pulmonary disease","author":"Brown","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib241","doi-asserted-by":"crossref","DOI":"10.4103\/0970-2113.116248","article-title":"Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS\/NCCP (I) recommendations","volume":"30","author":"Gupta","year":"2013","journal-title":"Lung India"},{"key":"10.1016\/j.ijtb.2022.06.004_bib242","series-title":"Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease","year":"2018"},{"key":"10.1016\/j.ijtb.2022.06.004_bib243","first-page":"108","article-title":"Nebulized albuterol versus levalbuterol in pediatric and adult patients: a review","volume":"44","author":"Borkowski","year":"2009","journal-title":"Formulary"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib244","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1378\/chest.123.1.128","article-title":"Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma","volume":"123","author":"Truitt","year":"2003","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.rmed.2007.10.007","article-title":"Formoterol Study Group Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients","volume":"102","author":"Gross","year":"2008","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib246","first-page":"107","article-title":"Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: results of a randomized, double-blind clinical study","volume":"9","author":"Kottakis","year":"2002","journal-title":"Can Respir J"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib247","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1185\/03007990802708152","article-title":"Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium\/albuterol MDI","volume":"25","author":"Sutherland","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib248","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s12325-009-0080-z","article-title":"Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease","volume":"26","author":"Tashkin","year":"2009","journal-title":"Adv Ther"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib249","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2165\/00003495-200969090-00005","article-title":"Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: results from a 6-week, randomized, placebo-controlled, clinical trial","volume":"69","author":"Hanania","year":"2009","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib250","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.rmed.2007.12.019","article-title":"Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial","volume":"102","author":"Tashkin","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib251","volume":"16","author":"Ferguson","year":"2018","journal-title":"The LANCET RESPIRATORY Published online September"},{"key":"10.1016\/j.ijtb.2022.06.004_bib115c","doi-asserted-by":"crossref","unstructured":"Menon M, Naik I, Rajawat GS, Nagarsenker M, Krishnaprasad K. Nebulized glycopyrronium, Formoterol and Budesonide aerosol aerodynamic assessment with vibrating mesh and compressor air nebulizer: Anderson Cascade Impactor study Jr of Drug Delivery and therapeutics : 9 (6), 2019","DOI":"10.22270\/jddt.v9i6.3465"},{"key":"10.1016\/j.ijtb.2022.06.004_bib253","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1183\/09031936.00004713","article-title":"Safety of formoterol in asthma clinical trials: an update","volume":"43","author":"Sears","year":"2014","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib254","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2147\/COPD.S753","article-title":"Role of arformoterol in the management of COPD","volume":"3","author":"King","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/15412550701816187","article-title":"Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials","volume":"5","author":"Hanrahan","year":"2008","journal-title":"COPD"},{"key":"10.1016\/j.ijtb.2022.06.004_bib256","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/COPD.S52557","article-title":"Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD","volume":"8","author":"Bollu","year":"2013","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib257","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.rmed.2008.12.014","article-title":"Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD","volume":"103","author":"Tashkin","year":"2009","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib258","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1378\/chest.14-0117","article-title":"One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD","volume":"146","author":"Donohue","year":"2014","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib259","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1517\/14740338.2015.998196","article-title":"Review of drug safety and efficacy of arformoterol in chronic obstructive pulmonary disease","volume":"14","author":"Loh","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib260","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/15412555.2019.1618256","article-title":"Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries With Chronic Obstructive Pulmonary","volume":"16","author":"Gilmer","year":"2019","journal-title":"Disease COPD"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib261","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.clinthera.2019.09.001","article-title":"Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators","volume":"41","author":"Allison","year":"2019","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib262","first-page":"158","article-title":"Practical problems with aerosol therapy in COPD","volume":"51","author":"Rau","year":"2006","journal-title":"Respir Care"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib263","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.4187\/respcare.01246","article-title":"Pediatric aerosol therapy: new devices and new drugs","volume":"56","author":"Rubin","year":"2011","journal-title":"Respir Care"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib264","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1008378","article-title":"Tiotropium versus salmeterol for the prevention of exacerbations of COPD","volume":"364","author":"Vogelmeier","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib265","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(13)70158-9","article-title":"Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study","volume":"1","author":"Decramer","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib266","doi-asserted-by":"crossref","first-page":"68A","DOI":"10.1378\/chest.1990041","article-title":"A randomized, double-blind, placebo-controlled study of SUN-101 (glycopyrrolate inhalation solution) in subjects with moderate to severe COPD (GOLDEN 2)","volume":"146","author":"Kerwin","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib267","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12931-017-0681-z","article-title":"Dose selection for glycopyrrolate\/eFlow\u00ae CS Phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) Phase II dose-finding studies","volume":"18","author":"Donohue","year":"2017","journal-title":"Respiratory Research"},{"key":"10.1016\/j.ijtb.2022.06.004_bib268","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bcp.12517","article-title":"Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease","volume":"79","author":"Leaker","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijtb.2022.06.004_bib269","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.rmed.2017.07.011","article-title":"Efficacy and safety of glycopyrrolate\/eFlow\u00ae CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials","volume":"132","author":"Kerwin","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/COPD.S184808","article-title":"Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4","volume":"14","author":"Ohar","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib271","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.rmed.2017.08.020","article-title":"Long-term safety of glycopyrrolate\/eFlow\u00ae CS in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 5 randomized study","volume":"132","author":"Ferguson","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib272","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4212\/cjhp.v65i2.1118","article-title":"Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease","volume":"65","author":"Batterink","year":"2012","journal-title":"Can. J. Hosp. Pharm."},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib273","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1378\/chest.128.1.48","article-title":"A Randomized Controlled Trial To Assess the Optimal Dose and Effect of Nebulized Albuterol in Acute Exacerbations of COPD","volume":"128","author":"Nair","year":"2005","journal-title":"CHEST"},{"issue":"Suppl 2","key":"10.1016\/j.ijtb.2022.06.004_bib274","first-page":"S1","article-title":"BTS guidelines of nebulization","volume":"52","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib275","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0954-6111(06)80270-2","article-title":"Dose of nebulized ipratropium bromide in acute severe asthma","volume":"85","author":"Whyte","year":"1991","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.ijtb.2022.06.004_bib276","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1513\/pats.P09ST2","article-title":"Managing Asthma Exacerbations in the Emergency Department Summary of the National Asthma Education and Prevention Program Expert Panel Report Guidelines for the Management of Asthma Exacerbations","volume":"6","author":"Camargo","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.ijtb.2022.06.004_bib277","first-page":"CD010179","article-title":"Addition of Intravenous beta(2)-agonists to Inhaled beta(2)-agonists for Acute Asthma","volume":"12","author":"Travers","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib278","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002984","article-title":"Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease","author":"Brown","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib279","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0012-3692(15)37638-8","article-title":"An evaluation of nebulized levalbuterol in stable COPD","volume":"124","author":"Datta","year":"2003","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib280","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1592\/phco.20.3.123.34776","article-title":"Levalbuterol Nebulizer Solution: Is It Worth Five Times the Cost of Albuterol?)","volume":"20","author":"Asmus","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijtb.2022.06.004_bib281","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4172\/2155-6121.1000123","article-title":"Levosalbutamol versus Salbutamol for Treatment of Acute Exacerbation of Asthma in BangladeshChildren","volume":"3","author":"Rahman","year":"2012","journal-title":"J Allergy Ther"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib282","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1067\/mai.2001.119152","article-title":"The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients","volume":"108","author":"Lotvall","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib283","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.rmed.2006.02.020","article-title":"Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: A randomized, double blind, single-dose, crossover study","volume":"101","author":"Janiter","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib284","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/thx.52.10.845","article-title":"Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine","volume":"52","author":"Cockcroft","year":"1997","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0736-4679(03)00133-1","article-title":"Levalbuterol is as effective as racemic albuterol in lowering serum potassium","volume":"25","author":"Pancu","year":"2003","journal-title":"J Emerg Med"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib286","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/02770900009055455","article-title":"Dose\u2013response evaluation of levalbuterol versus racemic albuterol in patients with asthma","volume":"37","author":"Handley","year":"2000","journal-title":"J Asthma"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib287","first-page":"2167","article-title":"Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial","volume":"29","author":"Nelson","year":"2007","journal-title":"ClinTher"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib288","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1753465808093934","article-title":"Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial","volume":"2","author":"Donohue","year":"2008","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib289","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/COPD.S11006","article-title":"Nebulized formoterol: a review of clinical efficacy and safety in COPD","volume":"5","author":"Gross","year":"2010","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib290","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.clinthera.2007.02.009","article-title":"Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial","volume":"29","author":"Baumgartner","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijtb.2022.06.004_bib291","article-title":"Nebulized arformoterol: what is its place in the management of COPD?","author":"Miles","year":"2012","journal-title":"Therapeutic Advances in Respiratory Disease First Published"},{"key":"10.1016\/j.ijtb.2022.06.004_bib292","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.clinthera.2009.08.012","article-title":"Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study","volume":"31","author":"Panettieri","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijtb.2022.06.004_bib293","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ppul.21446","article-title":"A cumulative dose, safety and tolerability study of arformoterol in pediatric subjects with stable asthma","volume":"46","author":"Hinkle","year":"2011","journal-title":"Pediatric Pulmonol"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib294","article-title":"Arformoterol: rationale for use in chronic obstructive pulmonary disease","volume":"4","author":"Jordan","year":"2014","journal-title":"Clin. Invest"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/15412550903499498","article-title":"The safety and efficacy of arformoterol and formoterol in COPD","volume":"7","author":"Hanania","year":"2010","journal-title":"COPD"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib296","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00003495-198019060-00001","article-title":"Flunisolide: a review of its pharmacological properties and therapeutic efficacy in rhinitis","volume":"19","author":"Pakes","year":"1980","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib297","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-199957050-00016","article-title":"Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages \u2264 500 \u03bccg\/day in adults and adolescents with mild to moderate asthma","volume":"57","author":"Jarvis","year":"1999","journal-title":"Drugs"},{"issue":"14","key":"10.1016\/j.ijtb.2022.06.004_bib298","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2165\/00003495-200565140-00005","article-title":"Budesonide inhalation suspension for the treatment of asthma in infants and children","volume":"65","author":"Berger","year":"2005","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib299","first-page":"145","article-title":"Inhaled corticosteroid therapy with nebulized beclomethasone dipropionate","volume":"23","author":"Nicolini","year":"2010","journal-title":"PulmPharmacolTher"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib300","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4187\/respcare.01414","article-title":"Nebulized Corticosteroids in Asthma and COPD. An Italian Appraisal","volume":"57","author":"Melani","year":"2012","journal-title":"Respir Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib301","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1016\/S0091-6749(99)70061-8","article-title":"Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma","volume":"104","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib302","first-page":"337","article-title":"The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children","volume":"31","author":"White","year":"1999","journal-title":"Fam Med"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib303","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2165\/00003495-200060050-00010","article-title":"Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders","volume":"60","author":"Hvizdos","year":"2000","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib304","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.clinthera.2007.06.005","volume":"29","author":"Murphy","year":"2007","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib305","first-page":"CD002310","article-title":"Fluticasone Versus Beclomethasone or Budesonide for Chronic Asthma in Adults and Children","author":"Adams","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib306","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1081\/JAS-200062966","article-title":"Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation","volume":"42","author":"De Benedictis","year":"2005","journal-title":"J Asthma"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib307","doi-asserted-by":"crossref","first-page":"372","DOI":"10.21037\/jtd.2017.02.51","article-title":"Comparison of fluticasone propionate with budesonide administered via nebulizer: a randomized controlled trial in patients with severe persistent asthma","volume":"9","author":"Lin","year":"2017","journal-title":"J Thorac Dis"},{"issue":"6-7","key":"10.1016\/j.ijtb.2022.06.004_bib308","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1651-2227.1993.tb12750.x","article-title":"A comparison between nebulized terbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age","volume":"82","author":"Daugbjerg","year":"1993","journal-title":"Acta Paediatr"},{"issue":"Suppl 18","key":"10.1016\/j.ijtb.2022.06.004_bib309","first-page":"93S","article-title":"The efficacy of combined inhaled steroids and \u03b22 agonist in the treatment of acute asthma in children 6-18 years of age versus inhaled \u03b22 agonist alone","volume":"7","author":"Bautista","year":"1994","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib310","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mpd.2001.116295","article-title":"A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma","volume":"139","author":"Tsai","year":"2001","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib311","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1651-2227.2005.tb01806.x","article-title":"The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma","volume":"94","author":"Sekerel","year":"2005","journal-title":"Acta Paediatr"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib312","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1067\/mai.2000.104784","article-title":"Inhaled budesonide for the treatment of acute wheezing and dyspnea in children up to 24 months old receiving intravenous hydrocortisone","volume":"105","author":"Sano","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib313","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1399-3038.2005.00317.x","article-title":"Co-administration of salbutamol and fluticasone for emergency treatment of children with moderate acute asthma","volume":"16","author":"Estrada-Reyes","year":"2005","journal-title":"Paediatr Allergy Immunol"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib314","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1398-9995.2009.02134.x","article-title":"Regular vs prn nebulized treatment in wheeze preschool children","volume":"64","author":"Papi","year":"2009","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib315","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1185\/030079907X188170","article-title":"Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications","volume":"23","author":"McLaughlin","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijtb.2022.06.004_bib316","series-title":"Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2019"},{"key":"10.1016\/j.ijtb.2022.06.004_bib317","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0009-9236(96)90216-7","article-title":"A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease","volume":"60","author":"Morice","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijtb.2022.06.004_bib318","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1164\/ajrccm.165.5.2109093","article-title":"Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease","volume":"165","author":"Maltais","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib319","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1183\/09031936.00047607","article-title":"The role of nebulised budesonide in the treatment of acute exacerbations of COPD","volume":"30","author":"Gunen","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib320","first-page":"3","article-title":"Nebulised budesonide in the treatment of acute exacerbations of chronic obstructive pulmonary disease","author":"Wei","year":"2004","journal-title":"Practical Clin Med Mag"},{"key":"10.1016\/j.ijtb.2022.06.004_bib321","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/0970-2113.71957","article-title":"Nebulized corticosteroids in the management of acute exacerbation of COPD","volume":"27","author":"Gaude","year":"2010","journal-title":"Lung India"},{"key":"10.1016\/j.ijtb.2022.06.004_bib322","first-page":"S11","article-title":"Clinical efficacy of nebulized budesonide with parental\/oral steroids in patients with acute exacerbation of COPD: A prospective study in tertiary care hospital","volume":"26","author":"Gaude","year":"2009","journal-title":"Lung India"},{"key":"10.1016\/j.ijtb.2022.06.004_bib323","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.clinthera.2007.06.005","volume":"29","author":"Murphy","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijtb.2022.06.004_bib324","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0954-6111(99)90035-5","article-title":"Oral steroid-sparing effect of two dose of nebulized fluticasone propionate and placebo in patients with severe chronic asthma","volume":"93","author":"Westbroek","year":"1999","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib325","first-page":"1665","article-title":"Nebulized step-down budesonide vs. fluticasone in infantile asthma: A retrospective cohort study","volume":"19","author":"Wu","year":"2020","journal-title":"Exper. Therap Med."},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib326","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.rmed.2011.01.005","article-title":"Inhaler mishandling remains common in real life and is associated with reduced disease control","volume":"105","author":"Melani","year":"2011","journal-title":"Respir Med"},{"issue":"5-6","key":"10.1016\/j.ijtb.2022.06.004_bib327","first-page":"231","article-title":"GENebu Project. Equipment and drugs used for home nebulizer therapy in Italy","volume":"57","author":"Melani","year":"2002","journal-title":"Monaldi Arch Chest Dis"},{"issue":"9203","key":"10.1016\/j.ijtb.2022.06.004_bib328","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(99)06290-X","article-title":"Suppression and recovery of adrenal response after short-term high-dose glucocrticoid treatment","volume":"355","author":"Henzen","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib329","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/ped.2010.0041","article-title":"A short burst of oral corticosteroid for children with acute asthma: is there an impact on immunity?","volume":"23","author":"Ducharme","year":"2010","journal-title":"Pediatric Allergy Immunology Pulmonogy"},{"issue":"3 Suppl","key":"10.1016\/j.ijtb.2022.06.004_bib330","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0091-6749(03)01859-1","article-title":"Inhaled corticosteroids: past lessons and future issues","volume":"112","author":"Allen","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib331","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/ph3030514","article-title":"Review inhaled corticosteroids","volume":"3","author":"Barnes","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijtb.2022.06.004_bib332","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/adc.87.6.457","article-title":"Survey of adrenal crisis associated with inhaled corticosteroids in the UK","volume":"87","author":"Todd","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ijtb.2022.06.004_bib333","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systemic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib334","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1203\/00006450-199701000-00007","article-title":"Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids","volume":"41","author":"Wolthers","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ijtb.2022.06.004_bib335","first-page":"652","article-title":"Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids","volume":"85","author":"Kannisto","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijtb.2022.06.004_bib336","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0954-6111(98)90039-7","article-title":"Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less","volume":"92","author":"Barnes","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib337","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pupt.2005.10.008","article-title":"Safety of inhaled corticosteroids: room for improvement","volume":"20","author":"Rossi","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"issue":"4 Pt 2","key":"10.1016\/j.ijtb.2022.06.004_bib338","doi-asserted-by":"crossref","first-page":"200S","DOI":"10.1016\/S0091-6749(99)70062-X","article-title":"Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma","volume":"104","author":"Scott","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib202a","doi-asserted-by":"crossref","unstructured":"J Price, W Lenney, C Duncan, L Green, Y Flood, P Daley-Yates, H Barnacle, J Efthimiou. HPA-axis effects of nebulised fluticasone propionate compared with oral prednisolone in childhood asthma. Respir Med. 202 Aug, 96(8) : 625-631.","DOI":"10.1053\/rmed.2002.1323"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib340","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1378\/chest.114.4.1022","article-title":"Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics","volume":"114","author":"Wilson","year":"1998","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib341","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1081-1206(10)62646-4","article-title":"Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children","volume":"83","author":"Kemp","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib342","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1399-3038.2008.00716.x","article-title":"Effects of nebulized corticosteroids on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze","volume":"19","author":"Cetinkaya","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib343","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJM200010123431501","article-title":"The Childhood Asthma Management Program. (CAMP) Research Group. Long-term effects of budesonide or nedocromil in children with asthma","volume":"343","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib344","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0091-6749(97)70072-1","article-title":"Attained adult height after childhood asthma: effect of glucocorticoid therapy","volume":"99","author":"Silverstein","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib345","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1056\/NEJM200010123431502","article-title":"Effect of long-term treatment with inhaled budesonide on adult height in children with asthma","volume":"343","author":"Agertoft","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib346","series-title":"Expert panel report 3: guidelines for the diagnosis and management of asthma","year":"2007"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib347","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133428","article-title":"Impact of inhaled corticosteroids on growth in children with asthma: systematic review and meta-analysis","volume":"10","author":"Loke","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2022.06.004_bib348","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1203229","article-title":"Effect of inhaled glucocorticoids in childhood on adult height","volume":"367","author":"Kelly","year":"2012","journal-title":"NEJM"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib349","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0091-6749(00)90074-5","article-title":"Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma","volume":"105","author":"Skoner","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib350","first-page":"189","article-title":"Cross-sectional study of bone density in asthmatic children","volume":"20","author":"Hopp","year":"1995","journal-title":"PediatrPulmonol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib351","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s001980050085","article-title":"Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate","volume":"8","author":"Gregson","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ijtb.2022.06.004_bib352","first-page":"CD003537","article-title":"Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease","volume":"1","author":"Jones","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijtb.2022.06.004_bib353","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1378\/chest.13-0871","article-title":"Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case\u2013control study","volume":"144","author":"McKeever","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib354","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archinternmed.2008.550","article-title":"Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis","volume":"169","author":"Singh","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib355","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","article-title":"Inhaled corticosteroids in COPD and the risk of serious pneumonia","volume":"68","author":"Suissa","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib356","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/cid\/cit472","article-title":"Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study","volume":"57","author":"Eurich","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib220a","doi-asserted-by":"crossref","unstructured":"Janson, C., Johansson, G., St\u00e4llberg, B., Karin Lisspers, Petter Olsson, Dorothy L. Keininger, Milica Uhde, Florian S. Gutzwiller, Leif J\u00f6rgensen & Kjell Larsson t al. Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study. Respir Res 1018; 19:172.","DOI":"10.1186\/s12931-018-0868-y"},{"key":"10.1016\/j.ijtb.2022.06.004_bib358","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1365-2222.2008.03029.x","article-title":"Dose\u2013response relationship for risk of non-vertebral fracture with inhaled corticosteroids","volume":"38","author":"Weatherall","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.ijtb.2022.06.004_bib359","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.1997.03540330044033","article-title":"Inhaled and nasal glucocorticoids and the risk of ocular hypertension or open-angle glaucoma","volume":"277","author":"Garbe","year":"1997","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib360","first-page":"120","article-title":"Inhaled steroids: effect on intraocular pressure in patients without glaucoma","volume":"31","author":"Samily","year":"1996","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib361","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.300.6739.1548","article-title":"Purpura and dermal thinning associated with high dose inhaled corticosteroids","volume":"300","author":"Capewell","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.ijtb.2022.06.004_bib362","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1183\/09031936.93.05091068","article-title":"Easy bruising as a side-effect of inhaled corticosteroids","volume":"5","author":"Mak","year":"1992","journal-title":"Eur Resp J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib363","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1183\/09031936.96.09020226","article-title":"Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency an association with adrenal function","volume":"9","author":"Roy","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib364","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1164\/ajrccm.153.3.8630563","article-title":"Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in\u00a0vivo","volume":"153","author":"Autio","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib365","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1056\/NEJM199906243402503","article-title":"Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease","volume":"340","author":"Pauwels","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib366","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0012-3692(15)31287-3","article-title":"Skin manifestations of inhaled corticosteroids in COPD patients: results from Lung Health Study II","volume":"126","author":"Tashkin","year":"2004","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib367","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-98-4-478","article-title":"Beclomethasone dipropionate for severe asthma during pregnancy","volume":"98","author":"Greenberger","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib368","first-page":"8","article-title":"Use of drugs during pregnancy-unique Swedish registration method that can be improved","volume":"1","author":"Ericson","year":"1999","journal-title":"Information from the Swedish Medical Products Agency"},{"key":"10.1016\/j.ijtb.2022.06.004_bib232a","doi-asserted-by":"crossref","unstructured":"Kallen B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. ObstetGynecol1999;93:392-395.","DOI":"10.1097\/00006250-199903000-00016"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib370","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1067\/mai.2003.1340","article-title":"Normal pregnancy outcomes in a population based study including 2968 pregnant women exposed to budesonide","volume":"111","author":"Norjavaara","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 292","key":"10.1016\/j.ijtb.2022.06.004_bib371","article-title":"Low frequency of adverse events reported through postmarketing surveillance for Pulmicort Respules (budesonide inhalation suspension) in the US adult population","volume":"109","author":"Cruz-Rivera","year":"2002","journal-title":"J All Clin Immunol"},{"issue":"Suppl 292","key":"10.1016\/j.ijtb.2022.06.004_bib372","article-title":"Safety of Pulmicort Respules (budesonide inhalation suspension) in geriatric patients: postmarketing surveillance and clinical study data","volume":"109","author":"Lyzell","year":"2002","journal-title":"J All Clin Immunol"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib373","article-title":"Proceedings of the American Thoracic Society :Safety of Inhaled Corticosteroids","volume":"1","author":"Tattersfield","year":"2004","journal-title":"All AnnalsATS"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib374","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.rmed.2015.07.007","article-title":"Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study","volume":"109","author":"Demirca","year":"2015","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib375","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/rmed.2000.0952","article-title":"Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma","volume":"94","author":"Manjra","year":"2000","journal-title":"Respir Med"},{"issue":"8-9","key":"10.1016\/j.ijtb.2022.06.004_bib376","first-page":"568","article-title":"Efficacy of nebulized fluticasone propionate in adult patients admitted to the emergency department due to bronchial asthma attack","volume":"10","author":"Starobin","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib377","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM200009073431003","article-title":"A Comparison of Inhaled Fluticasone and Oral Prednisone for Children with Severe Acute Asthma","volume":"343","author":"Schuh","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib378","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/1744666X.4.6.723","article-title":"Inhaled corticosteroids as rescue medication in acute severe asthma","volume":"4","author":"Rodrigo","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib379","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1378\/chest.130.5.1301","article-title":"Rapid effects of inhaled corticosteroids in acute asthma. An evidence-based evaluation","volume":"130","author":"Rodrigo","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib380","first-page":"CD002316","article-title":"Inhaled steroids in acute asthma following emergency department discharge","volume":"3","author":"Edmonds","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijtb.2022.06.004_bib381","first-page":"CD002308","article-title":"Early use of inhaled corticosteroids in the emergency department treatment of acute asthma","volume":"3","author":"Edmonds","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib382","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.rmed.2006.10.009","article-title":"Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: a review of the evidence","volume":"101","author":"Volovitz","year":"2007","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib383","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5415\/apallergy.2012.2.1.76","article-title":"Magnesium sulfate for acute asthma in adults: a systematic literature review","volume":"2","author":"Song","year":"2012","journal-title":"Asia Pac Allergy"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib384","first-page":"169","article-title":"Inhalational therapy with magnesium sulfate an salbutamol sulfate in bronchial asthma","volume":"38","author":"Meral","year":"1996","journal-title":"Turk J Pediatr"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib385","first-page":"29","article-title":"Inhaled magnesium sulfate in the treatment of severe asthma","volume":"19","author":"Talukar","year":"2005","journal-title":"Indian J Allergy Asthma Immunol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib386","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1183\/09031936.98.12020341","article-title":"Nebulized magnesium sulphate versus nebulized salbutamol in acute bronchial asthma: a clinical trial","volume":"12","author":"Mangat","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib387","first-page":"193","volume":"108","author":"Nannini","year":"2000"},{"key":"10.1016\/j.ijtb.2022.06.004_bib388","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0140-6736(03)13721-X","article-title":"Use of isotonic nebulized magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomized placebo-controlled trial","volume":"361","author":"Hughes","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib389","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jemermed.2004.02.006","article-title":"Comparison of nebulized magnesium sulfate plus albuterol to nebulized albuterol plus saline in children with acute exacerbations of mild to moderate asthma","volume":"27","author":"Mahajan","year":"2004","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib390","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2147\/DDDT.S103147","article-title":"The efficacy of nebulized magnesium sulfate alone and in combination with salbutamol in acute asthma","volume":"10","author":"Sarhan","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ijtb.2022.06.004_bib391","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1067\/mem.2002.123300","article-title":"A randomized clinical trial of nebulized magnesium sulfate in addition to albuterol in treatment of acute mild-to-moderate asthma exacerbations in adults","volume":"39","author":"Bessmertny","year":"2002","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib392","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.pupt.2005.03.003","article-title":"A randomized controlled trial of magnesium sulphate as a vehicle for nebulized salbutamol in the treatment of moderate to severe asthma attacks","volume":"18","author":"Kokturk","year":"2005","journal-title":"Pulm pharmacol ther"},{"key":"10.1016\/j.ijtb.2022.06.004_bib393","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/emj.2005.026203","article-title":"Comparison of nebulized magnesium sulphate and salbutamol combined with salbutamol alone in the treatment of acute bronchial asthma: a randomized study","volume":"23","author":"Aggarwal","year":"2006","journal-title":"Emerg Med J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib394","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003898.pub4","article-title":"Inhaled magnesium sulfate in the treatment of acute asthma (review)","volume":"4","author":"Blitz","year":"2005","journal-title":"The Cochrane Database Of Systematic Reviews"},{"key":"10.1016\/j.ijtb.2022.06.004_bib395","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1345\/aph.1G496","article-title":"Nebulized magnesium sulfate in the management of acute exacerbation of asthma","volume":"40","author":"Villeneuve","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijtb.2022.06.004_bib396","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/emj.2007.052050","article-title":"Intravenous and nebulized magnesium sulphate for acute asthma: systemic review and meta-analysis","volume":"24","author":"Mohammed","year":"2007","journal-title":"Emerg Med J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib397","article-title":"Inhaled magnesium sulfate in the treatment of acute asthma (review)","volume":"12","author":"Powell","year":"2012","journal-title":"Cochrane Database Of Systematic Reviews"},{"key":"10.1016\/j.ijtb.2022.06.004_bib398","article-title":"Inhaled magnesium sulfate in the treatment of acute asthma (review)","volume":"11","author":"Knightly","year":"2017","journal-title":"Cochrane Database Of Systematic Reviews"},{"key":"10.1016\/j.ijtb.2022.06.004_bib399","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/ageing\/17.4.275","article-title":"Inhaler technique in the elderly","volume":"17","author":"Armitage","year":"1988","journal-title":"Age Ageing"},{"key":"10.1016\/j.ijtb.2022.06.004_bib400","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02983691","article-title":"Assessment of inhaler technique in general practice","volume":"158","author":"Buckley","year":"1989","journal-title":"Ir J Med Sci"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib401","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/thx.2007.086041","article-title":"Patient adherence in COPD","volume":"63","author":"Bourbeau","year":"2008","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib402","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccm.2005.05.004","article-title":"Aging of the respiratory system: impact on pulmonary function tests and adaptation to exertion","volume":"26","author":"Janssens","year":"2005","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib403","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/ciia.2006.1.3.253","article-title":"Effect of aging on respiratory system physiology and immunology","volume":"1","author":"Sharma","year":"2006","journal-title":"Clin Interv Aging"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib404","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1183\/09031936.00125109","article-title":"Cognitive function in COPD","volume":"35","author":"Dodd","year":"2010","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib405","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ageing\/26.2.83","article-title":"Competence thresholds for the use of inhalers in people with dementia","volume":"26","author":"Allen","year":"1997","journal-title":"Age Ageing"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib406","first-page":"1182","article-title":"Inhaler technique of outpatients in the home","volume":"45","author":"Johnson","year":"2000","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib407","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4140\/TCP.n.2015.92","article-title":"Inhaler misuse in an older adult population","volume":"30","author":"Vanderman","year":"2015","journal-title":"Consult Pharm"},{"issue":"Suppl 2","key":"10.1016\/j.ijtb.2022.06.004_bib408","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1136\/thx.52.2008.S53","article-title":"Nebulizers for the elderly","volume":"52","author":"Pounsford","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib409","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.96.6.1237","article-title":"Comparison of Outpatient Nebulized vs Metered Dose Inhaler Terbutaline in Chronic Airflow Obstruction","volume":"96","author":"Mestitz","year":"1989","journal-title":"Chest"},{"issue":"15","key":"10.1016\/j.ijtb.2022.06.004_bib410","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/archinte.1997.00440360162018","article-title":"bronchodilator delivery in acute airflow obstruction. A meta-analysis","volume":"157","author":"Turner","year":"1997","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib411","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1378\/chest.91.6.804","article-title":"Comparison of domiciliary nebulized salbutamol from a metered dose inhaler in stable chronic airflow limitation","volume":"91","author":"Jenkins","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib412","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0007-0971(86)90038-0","article-title":"Comparison of metered dose inhalers with nebulizers for the delivery of ipratropium bromide in domiciliary practice","volume":"80","author":"Gunarwardena","year":"1986","journal-title":"Br J Dis Chest"},{"issue":"Suppl 8","key":"10.1016\/j.ijtb.2022.06.004_bib413","first-page":"13","article-title":"Delivery system selection: clinical considerations","volume":"1","author":"Filuk","year":"2008","journal-title":"Am Health Drug Benefits"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib414","article-title":"Opportunities for inhaler device selection in elderly patients with asthma or COPD","volume":"2015","author":"Barrons","year":"2015","journal-title":"Dovepress"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib415","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/jam.2000.13.25","article-title":"Effectiveness and acceptability of domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer","volume":"13","author":"Balzano","year":"2000","journal-title":"J Aerosol Med"},{"issue":"60","key":"10.1016\/j.ijtb.2022.06.004_bib416","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/rmed.2001.1292","article-title":"Survey of patients\u2019 views of domiciliary nebuliser treatment for chronic lung disease","volume":"96","author":"Barta","year":"2002","journal-title":"Respir Med"},{"issue":"Suppl 2","key":"10.1016\/j.ijtb.2022.06.004_bib417","first-page":"S1","article-title":"Current best practice for nebuliser treatment. British Thoracic Society Nebulizer Project Group","volume":"52","author":"Muers","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib418","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jaci.2010.05.035","article-title":"Asthma in elderly: diagnosis and management","volume":"126","author":"Reed","year":"2010","journal-title":"J Allergy Clin Immol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib419","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/thx.36.7.523","article-title":"Influence of age on response to ipratropium and salbutamol in asthma","volume":"3 6","author":"Ullah","year":"1981","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib420","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0954-6111(08)80071-6","article-title":"Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction","volume":"84","author":"Barros","year":"1990","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib421","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1532-5415.1988.tb04379.x","article-title":"Decreased receptor activation with age: can it be explained by desensitization?","volume":"36","author":"Scarpace","year":"1988","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ijtb.2022.06.004_bib422","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00002512-199813050-00003","article-title":"Drug dosage in the elderly: is it rational?","volume":"13","author":"Turnheim","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ijtb.2022.06.004_bib423","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2147\/CIA.S33609","article-title":"Management of asthma in the elderly patient","volume":"8","author":"Melani","year":"2013","journal-title":"Clin Interv Aging"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib424","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00134-015-4114-5","article-title":"Aerosol therapy in intensive and intermediate care units: prospective observation of 2808 critically ill patients","volume":"42","author":"Ehrmann","year":"2016","journal-title":"Intensive care medicine"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib425","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s00134-013-2872-5","article-title":"Aerosol therapy during mechanical ventilation: an international survey","volume":"39","author":"Ehrmann","year":"2013","journal-title":"Intensive care medicine"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib426","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/ajrccm\/147.5.1279","article-title":"Lung distribution and pharmacokinetics of aerosolized tobramycin","volume":"147","author":"Le Conte","year":"1993","journal-title":"The American review of respiratory disease"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib427","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00003246-198502000-00005","article-title":"Aerosol Delivery in Intubated, Mechanically Ventilated Patients","volume":"13","author":"MacIntyre","year":"1985","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib428","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/ajrccm\/147.3.524","article-title":"Deposition in asthmatics of particles inhaled in air or in helium-oxygen","volume":"147","author":"Anderson","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib429","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/ajrccm.163.1.2003025","article-title":"Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation","volume":"163","author":"Goode","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib430","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13054-016-1448-5","article-title":"Fundamentals of aerosol therapy in critical care","volume":"20","author":"Dhanani","year":"2016","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib431","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1164\/ajrccm\/140.6.1607","article-title":"Comparison of plasma concentrations of aerosolized pentamidine in nonventilated and ventilated patients with pneumocystosis","volume":"140","author":"Girard","year":"1989","journal-title":"The American Review of Respiratory Disease"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib432","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/ajrccm\/141.2.440","article-title":"Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs","volume":"141","author":"Fuller","year":"1990","journal-title":"The American Review of Respiratory Disease"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib433","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/jac\/dkh326","article-title":"Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients","volume":"54","author":"Badia","year":"2004","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib434","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13054-017-1844-5","article-title":"Aerosol delivery during invasive mechanical ventilation: a systematic review","volume":"21","author":"Dugernier","year":"2017","journal-title":"Critical Care (London, England)"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib435","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4187\/respcare.02217","article-title":"Adjunct Therapies During Mechanical Ventilation: Airway Clearance Techniques, Therapeutic Aerosols, and Gases","volume":"58","author":"Kallet","year":"2013","journal-title":"Respir Care"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib436","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0970-2113.92361","article-title":"Pulmonary drug delivery strategies: A concise, systematic review","volume":"29","author":"Patil","year":"2012","journal-title":"Lung India"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib437","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1186\/cc8206","article-title":"Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia","volume":"13","author":"Luyt","year":"2009","journal-title":"Critical care (London, England)"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib438","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/jamp.2010.0860","article-title":"Pharmacokinetics and tolerability of amikacin administered as BAY41-6551 aerosol in mechanically ventilated patients with gram-negative pneumonia and acute renal failure","volume":"24","author":"Luyt","year":"2011","journal-title":"Journal of aerosol medicine and pulmonary drug delivery"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib439","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/jamp.2013.1100","article-title":"A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow(R) inline nebulizer system in mechanically ventilated patients","volume":"27","author":"Montgomery","year":"2014","journal-title":"Journal of aerosol medicine and pulmonary drug delivery"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib440","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00134-011-2420-0","article-title":"BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia","volume":"38","author":"Niederman","year":"2012","journal-title":"Intensive care medicine"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib441","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1592\/phco.22.12.972.33596","article-title":"Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients","volume":"22","author":"Wood","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib442","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00000542-200207000-00028","article-title":"Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia","volume":"97","author":"Elman","year":"2002","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib443","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/00000542-200304000-00033","article-title":"Lack of lung tissue and systemic accumulation after consecutive daily aerosols of amikacin in ventilated piglets with healthy lungs","volume":"98","author":"Ferrari","year":"2003","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib444","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1007\/s00134-009-1605-2","article-title":"Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa","volume":"35","author":"Ferrari","year":"2009","journal-title":"Intensive care medicine"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib445","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00134-008-1126-4","article-title":"Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers","volume":"34","author":"Ferrari","year":"2008","journal-title":"Intensive care medicine"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib446","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1164\/ajrccm.165.2.2107025","article-title":"Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs","volume":"165","author":"Goldstein","year":"2002","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib447","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/jamp.2014.1164","article-title":"Aerosol Route to Administer Teicoplanin in Mechanical Ventilation: In\u00a0Vitro Study, Lung Deposition and Pharmacokinetic Analyses in Pigs","volume":"28","author":"Guillon","year":"2015","journal-title":"Journal of aerosol medicine and pulmonary drug delivery"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib448","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00134-010-1879-4","article-title":"Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa","volume":"36","author":"Lu","year":"2010","journal-title":"Intensive care medicine"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib449","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/00000542-200505000-00019","article-title":"Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen","volume":"102","author":"Tonnellier","year":"2005","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib450","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1164\/ajrccm.151.6.7767526","article-title":"Bronchodilator delivery by metered-dose inhaler in ventilator-supported patients","volume":"151","author":"Dhand","year":"1995","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib451","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ppul.21376","article-title":"Higher tobramycin concentration and vibrating mesh technology can shorten antibiotic treatment time in cystic fibrosis","volume":"46","author":"Coates","year":"2011","journal-title":"Pediatric pulmonology"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib452","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ppul.20850","article-title":"Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: a pilot project","volume":"43","author":"Coates","year":"2008","journal-title":"Pediatric pulmonology"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib453","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1753465813508445","article-title":"Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis","volume":"8","author":"Stockmann 1","year":"2014","journal-title":"Ther Adv Respir Dis"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib454","article-title":"Practice pattern of aerosol therapy among patients undergoing mechanical ventilation in mainland China: A web-based survey involving 447 hospitals","volume":"14","author":"Zhang","year":"2019","journal-title":"China Union of Respiratory Care (CURC) PLoS One"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib455","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/ajrccm.156.1.9610025","article-title":"Inhaled bronchodilator therapy in mechanically ventilated patients","volume":"156","author":"Dhand","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib456","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4187\/respcare.05803","article-title":"How should aerosols be delivered during invasive mechanical ventilation?","volume":"62","author":"Dhand","year":"2017","journal-title":"Respiratory Care October"},{"issue":"6 Pt 1","key":"10.1016\/j.ijtb.2022.06.004_bib457","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1567","article-title":"Metered-dose inhaler versus nebulized albuterol in mechanically ventilated patients","volume":"148","author":"Manthous","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib458","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF03256657","article-title":"Adverse effects of beta-agonists: are they clinically relevant?","volume":"2","author":"Abramson","year":"2003","journal-title":"Am J Respir Med"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib459","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1081-1206(10)62711-1","article-title":"Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma","volume":"81","author":"Ramsdell","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib460","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1378\/chest.127.1.335","article-title":"Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians\/American College of Asthma, Allergy, and Immunology","volume":"127","author":"Dolovich","year":"2005","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib461","first-page":"154","article-title":"Utilization of bronchodilators in ventilated patients without obstructive airways disease","volume":"52","author":"Chang","year":"2007","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib462","first-page":"152","article-title":"Bronchodilator therapy in mechanically ventilated patients: patient selection and clinical outcomes","volume":"52","author":"Dhand","year":"2007","journal-title":"Respir Care"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib463","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kaalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ijtb.2022.06.004_bib464","first-page":"S1","article-title":"Guidelines for Antibiotic Prescription in Intensive Care Unit","volume":"23","author":"Khilnani","year":"2019","journal-title":"Indian Journal of Critical Care Medicine"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib465","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF00273544","article-title":"The effect of mucolytic and bronchodilator aerosol therapy on airway resistance in mechanically ventilated patients","volume":"11","author":"Zandstra","year":"1985","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib466","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1164\/ajrccm.159.1.9803119","article-title":"Reconciling in\u00a0vitro and in\u00a0vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors","volume":"159","author":"Fink","year":"1999","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib467","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4187\/respcare.02782","article-title":"Improving aerosol drug delivery during invasive mechanical ventilation with redesigned components","volume":"59","author":"Longest","year":"2014","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib468","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1378\/chest.118.3.884-a","article-title":"In-line Suction Catheters May Impede Aerosol Delivery to Patients Receiving Mechanical Ventilation","volume":"118","author":"Manthous","year":"2000","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib469","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1164\/ajrccm\/145.5.1117","article-title":"Nebulizer function during mechanical ventilation","volume":"145","author":"O'Riordan","year":"1992","journal-title":"The American review of respiratory disease"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib470","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1478-5153.2010.00395.x","article-title":"Factors affecting bronchodilator delivery in mechanically ventilated adults","volume":"15","author":"Ari","year":"2010","journal-title":"Nursing in critical care"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib471","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/jamp.2011.0936","article-title":"Inhalation therapy in patients receiving mechanical ventilation: an update","volume":"25","author":"Ari","year":"2012","journal-title":"Journal of aerosol medicine and pulmonary drug delivery"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib472","first-page":"1336","article-title":"Influence of moisture accumulation in inline spacer on delivery of aerosol using metered-dose inhaler during mechanical ventilation","volume":"54","author":"Lin","year":"2009","journal-title":"Respiratory care"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib473","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s41030-018-0060-z","article-title":"Aerosol Delivery to a Critically Ill Patient: A Big Issue Easily Solved by Developing Guidelines","volume":"4","author":"Abdelrahim","year":"2018","journal-title":"Pulm Ther"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib474","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4187\/respcare.05015","article-title":"Effects of heat and moisture exchangers and exhaled humidity on aerosol deposition in a simulated ventilator-dependent adult lung model","volume":"62","author":"Ari","year":"2017","journal-title":"Respir Care"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib475","first-page":"1331","article-title":"Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients","volume":"50","author":"Dhand","year":"2005","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib476","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1183\/09031936.96.09030585","article-title":"Bronchodilator delivery with metered-dose inhalers in mechanically ventilated patients","volume":"9","author":"Dhand","year":"1996","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib477","first-page":"609","article-title":"Nebulizers: principles and performance","volume":"45","author":"Hess","year":"2000","journal-title":"Respiratory care"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib478","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1378\/chest.106.6.1788","article-title":"A comparison of commercial jet nebulizers","volume":"106","author":"Loffert","year":"1994","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib479","first-page":"1257","article-title":"Design principles of liquid nebulization devices currently in use","volume":"47","author":"Rau","year":"2002","journal-title":"Respir Care"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib480","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1183\/09031936.97.10040905","article-title":"Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation","volume":"10","author":"Harvey","year":"1997","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib481","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0954-6111(94)90046-9","article-title":"The therapeutic use of ultrasonic nebulizers in acute asthma","volume":"88","author":"Phillips","year":"1994","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib482","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/17434440.5.1.9","article-title":"Pulmonary Drug Delivery System for inhalation therapy in mechanically ventilated patients","volume":"5","author":"Dhand","year":"2008","journal-title":"Expert Rev Med Devices"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib483","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1378\/chest.97.6.1327","article-title":"Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration","volume":"97","author":"Phipps","year":"1990","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib484","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0928-0987(03)00148-9","article-title":"Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers","volume":"19","author":"Steckel","year":"2003","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib485","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/03639040802144211","article-title":"Current therapies and technological advances in aqueous aerosol drug delivery","volume":"34","author":"Watts","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib486","first-page":"817","article-title":"Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response","volume":"45","author":"Duarte","year":"2000","journal-title":"Respir Care"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib487","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1378\/chest.107.1.210","article-title":"Treatment of bronchospasm by metered-dose inhaler albuterol in mechanically ventilated patients","volume":"107","author":"Manthous","year":"1995","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib488","first-page":"1406","article-title":"Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol","volume":"47","author":"Dhand","year":"2002","journal-title":"Respir Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib489","first-page":"1","article-title":"In\u00a0vitro aerodynamic characteristics of aerosol delivered from different inhalation methods in mechanical ventilation","volume":"30","author":"El Hansy","year":"2016","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib490","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/jam.2007.0538","article-title":"Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer","volume":"20","author":"Waldrep","year":"2007","journal-title":"J Aerosol Med"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib491","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.4187\/respcare.01246","article-title":"Pediatric aerosol therapy: new devices and new drugs","volume":"56","author":"Rubin","year":"2011","journal-title":"Respir Care"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib492","first-page":"845","article-title":"Influence of Nebulizer Type, Position, and Bias Flow on Aerosol Drug Delivery in Simulated Pediatric and Adult Lung Models During Mechanical Ventilation","volume":"55","author":"Ari","year":"2010","journal-title":"Respir Care"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib493","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1164\/ajrccm.161.5.9909032","article-title":"Overcoming the adverse effect of humidity in aerosol delivery via pressurized metered-dose inhalers during mechanical ventilation","volume":"161","author":"Lange","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib494","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4187\/respcare.03790","article-title":"Aerosol Therapy in Pulmonary Critical Care","volume":"60","author":"Ari","year":"2015","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib495","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ccm.2008.02.003","article-title":"How best to deliver aerosol medications to mechanically ventilated patients","volume":"29","author":"Dhand","year":"2008","journal-title":"Clinics in Chest Medicine"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib496","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/jamp.2007.0663","article-title":"Aerosol delivery during mechanical ventilation: from basic techniques to new devices","volume":"21","author":"Dhand","year":"2008","journal-title":"J Aer Med Pulm Drug Del"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib497","first-page":"1036","article-title":"Effects of aerosol inhalation on respiratory mechanical parameters under different ventilation patterns and ventilator parameters","volume":"30","author":"Wang","year":"2018","journal-title":"Chin J Crit Care Med"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib498","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1164\/rccm.200210-1167OC","article-title":"Aerosol delivery and modern mechanical ventilation: in\u00a0vitro\/in\u00a0vivo evaluation","volume":"168","author":"Miller","year":"2003","journal-title":"Am J Resp. Crit Care Med."},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib499","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00134-005-2594-4","article-title":"In\u00a0vitro study and semiempirical model for aerosol delivery control during mechanical ventilation","volume":"31","author":"Vecellio","year":"2005","journal-title":"Intensive Care Medicine"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib500","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jamp.2007.0630","article-title":"Inhaled bronchodilator administration during mechanical ventilation: how to optimize it, and for which clinical benefit?","volume":"21","author":"Guerin","year":"2008","journal-title":"J Aer Med Pulm Drug Del"},{"issue":"17","key":"10.1016\/j.ijtb.2022.06.004_bib501","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.21037\/atm-20-1313","article-title":"The utilization of aerosol therapy in mechanical ventilation patients: a prospective multicenter observational cohort study and a review of the current evidence","volume":"8","author":"Lyu","year":"2020","journal-title":"Ann Transl. Med."},{"issue":"4_part_1","key":"10.1016\/j.ijtb.2022.06.004_bib502","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1164\/ajrccm\/148.4_Pt_1.872","article-title":"Delivery of ultrasonic nebulized aerosols to a lung model during mechanical ventilation","volume":"148","author":"Thomas","year":"1993","journal-title":"Am. Rev Respir Dis."},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib503","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4187\/respcare.05344","article-title":"The effect of nebulizer position on aerosolized epoprostenol delivery in an adult lung model","volume":"62","author":"Anderson","year":"2017","journal-title":"Respir Care"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib504","first-page":"837","article-title":"Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation","volume":"55","author":"Ari","year":"2010","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib505","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1164\/ajrccm\/146.2.383","article-title":"Delivery of a nebulized aerosol to a lung model during mechanical ventilation. Effect of ventilator settings and nebulizer type, position, and volume of fill","volume":"146","author":"O'Doherty","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib506","first-page":"1131","article-title":"Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency","volume":"32","author":"Hughes","year":"1987","journal-title":"Respir Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib507","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pupt.2017.06.004","article-title":"Inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during invasive mechanical ventilation","volume":"45","author":"ElHansy","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib508","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.4187\/respcare.02074","article-title":"Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in\u00a0vitro model","volume":"58","author":"Berlinski","year":"2013","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib509","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/jamp.2014.1131","article-title":"Influence of inspiratory flow pattern and nebulizer position on aerosol delivery with a vibrating-mesh nebulizer during invasive mechanical ventilation: an in\u00a0vitro analysis","volume":"28","author":"Dugernier","year":"2015","journal-title":"J Aer Med Pulm Drug Del"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib510","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13054-016-1448-5","article-title":"Fundamentals of aerosol therapy in critical care","volume":"20","author":"Dhanani","year":"2016","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib511","first-page":"423","article-title":"Effect of a new nebulizer position on aerosol delivery during mechanical ventilation: a bench study","volume":"37","author":"Quinn","year":"1992","journal-title":"Respir Care"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib512","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.hrtlng.2008.12.005","article-title":"Placement of the nebulizer before the humidifier during mechanical ventilation: Effect on aerosol delivery","volume":"38","author":"Moraine","year":"2009","journal-title":"Heart & Lung"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib513","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.4187\/respcare.08470","article-title":"Innovation in aerosol drug delivery during adult mechanical ventilation","volume":"65","author":"Berlinski","year":"2020","journal-title":"Respiratory Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib514","article-title":"The Clinical Practice and Best Aerosol Delivery Location in Intubated and Mechanically Ventilated Patients: A Randomized Clinical Trial","volume":"2021","author":"Zhang","year":"2021","journal-title":"Biomed Res Int"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib515","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.4187\/respcare.04013","article-title":"Ariel Berlinski and J Randy Willis Effect of Tidal Volume and Nebulizer Type and Position on AlbuterolDelivery in a Pediatric Model of Mechanical Ventilation","volume":"60","year":"2015","journal-title":"Respir Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib516","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12890-017-0568-2","article-title":"The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial","volume":"18","author":"Dentice","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib517","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/ajrccm.154.2.8756811","article-title":"Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients","volume":"154","author":"Dhand","year":"1996","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib518","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1183\/09031936.98.12010165","article-title":"Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of end-inspiratory pause","volume":"12","author":"Mouloudi","year":"1998","journal-title":"European Respiratory Journal"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib519","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s001340051049","article-title":"Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of tidal volume","volume":"25","author":"Mouloudi","year":"1999","journal-title":"Intensive care medicine"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib520","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1034\/j.1399-3003.2000.16b13.x","article-title":"Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern","volume":"16","author":"Mouloudi","year":"2000","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib521","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1213\/01.ane.0000167276.92462.ba","article-title":"The Effects of Nebulized Salbutamol, External Positive End-Expiratory Pressure, and Their Combination on Respiratory Mechanics, Hemodynamics, and Gas Exchange in Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients","volume":"101","author":"Tzoufi","year":"2005","journal-title":"Anesthesia & Analgesia."},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib522","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/cc7117","article-title":"Duration of salmeterol-induced bronchodilation in mechanically ventilated chronic obstructive pulmonary disease patients: a prospective clinical study","volume":"12","author":"Malliotakis","year":"2008","journal-title":"Critical care (London, England)"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib523","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc3020","article-title":"Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis","volume":"9","author":"Michalopoulos","year":"2005","journal-title":"Critical care (London, England)"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib524","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.cmi.2017.03.018","article-title":"Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients","volume":"23","author":"Rello","year":"2017","journal-title":"Clinical Microbiology and Infection"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib525","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ppul.1950020108","article-title":"The delivery of therapeutic aerosols through endotracheal tubes","volume":"2","author":"Ahrens","year":"1986","journal-title":"Pediatric pulmonology"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib526","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/00000542-198906000-00021","article-title":"Delivery efficiency of metered dose aerosols given via endotracheal tubes","volume":"70","author":"Crogan","year":"1989","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib527","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1164\/ajrccm.149.1.8111585","article-title":"Aerosol deposition in mechanically ventilated patients: optimizing nebulizer delivery","volume":"149","author":"O'Riordan","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib528","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.4187\/respcare.04125","article-title":"Pressurized metered-dose inhalers versus nebulizers in the treatment of mechanically ventilated subjects with artificial airways: an in\u00a0vitro study","volume":"60","author":"Ari","year":"2015","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib529","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/jamp.2011.0962","article-title":"Aerosol delivery through tracheostomy tubes: an in\u00a0vitro study","volume":"26","author":"Pitance","year":"2013","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"2 Suppl","key":"10.1016\/j.ijtb.2022.06.004_bib530","first-page":"27S","article-title":"Aerosol deposition to the lungs by MDI in ventilated patients: endotracheal tubes vs tracheostomy","volume":"98","author":"Fuller","year":"1990","journal-title":"Chest"},{"issue":"2 Pt 1","key":"10.1016\/j.ijtb.2022.06.004_bib531","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1164\/ajrccm.154.2.8756810","article-title":"Aerosol delivery from a metered-dose inhaler during mechanical ventilation. An in\u00a0vitro model","volume":"154","author":"Fink","year":"1996","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib532","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00134-003-1792-1","article-title":"In\u00a0vitro evaluation of aerosol bronchodilator delivery during mechanical ventilation: pressure-control vs. volume control ventilation","volume":"29","author":"Hess","year":"2003","journal-title":"Intensive care medicine"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib533","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13613-016-0169-x","article-title":"Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study","volume":"6","author":"Dugernier","year":"2016","journal-title":"Annals of Intensive Care"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib534","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/jamp.2014.1131","article-title":"Influence of inspiratory flow pattern and nebulizer position on aerosol delivery with a vibrating-mesh nebulizer during invasive mechanical ventilation: an in\u00a0vitro analysis","volume":"28","author":"Dugernier","year":"2015","journal-title":"Journal of aerosol medicine and pulmonary drug delivery"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib535","first-page":"329","article-title":"Effects of inhaled fenoterol and positive end-expiratory pressure on the respiratory mechanics of patients with chronic obstructive pulmonary disease","volume":"12","author":"Gu\u00e9rin","year":"2005","journal-title":"Can Respir J"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib536","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1164\/rccm.201011-1894OC","article-title":"Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa","volume":"184","author":"Lu","year":"2011","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib537","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2044.2006.04897.x","article-title":"Use of helium-oxygen mixture in adult patients presenting with exacerbations of asthma and chronic obstructive pulmonary disease: a systematic review","volume":"62","author":"Colebourn","year":"2007","journal-title":"Anesthesia"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib538","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1542\/peds.2012-1317","article-title":"Heliox therapy in bronchiolitis: phase III multicentre double-blind randomized controlled trial","volume":"131","author":"Chowdhury","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijtb.2022.06.004_bib539","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1378\/chest.129.3.676","article-title":"Clinical effects of heliox administration for acute bronchiolitis in young infants","volume":"129","author":"Cambonie","year":"2006","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib540","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1378\/chest.98.3.693","article-title":"Castriotta Helium\u2013oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis","volume":"98","author":"Gluck","year":"1990","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib541","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1097\/00003246-199912000-00010","article-title":"Hall Oxygenation in status asthmaticus improves during ventilation with helium\u2013oxygen","volume":"27","author":"Schaeffer","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib542","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1097\/00003246-199911000-00017","article-title":"Chevrolet JC Beneficial effects of helium: oxygen versus air: oxygen non-invasive pressure support in patients with decompensated chronic obstructive pulmonary disease","volume":"27","author":"Jolliet","year":"1999","journal-title":"Crit Care Med"},{"issue":"4 Pt 1","key":"10.1016\/j.ijtb.2022.06.004_bib543","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1164\/ajrccm.161.4.9904065","article-title":"Non-invasive ventilation with helium\u2013oxygen in acute exacerbations of chronic obstructive pulmonary disease","volume":"161","author":"Jaber","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib544","first-page":"611","article-title":"Basic Techniques for Aerosol Delivery During Mechanical Ventilation","volume":"49","author":"Dhand","year":"2004","journal-title":"Respir Care"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib545","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/ajrccm.163.1.2003025","article-title":"Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation","volume":"163","author":"Goode","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib546","first-page":"184","article-title":"The effect of heliox on nebulizer function using a beta-agonist bronchodilator","volume":"115","author":"Hess","year":"1999","journal-title":"JrChest"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib547","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1592\/phco.19.3.143.30920","article-title":"Effect of helium-oxygen on delivery of albuterol in a pediatric, volume-cycled, ventilated lung model","volume":"19","author":"Habib","year":"1999","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib548","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1164\/ajrccm.160.1.9807127","article-title":"Calibration of seven ICU ventilators for mechanical ventilation with helium-oxygen mixtures","volume":"160","author":"Tassaux","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib549","first-page":"582","article-title":"Respiratory controversies in the critical care setting. Should heliox be used for mechanically ventilated patients?","volume":"52","author":"Hurford","year":"2007","journal-title":"Respir Care"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib550","doi-asserted-by":"crossref","first-page":"880","DOI":"10.4187\/respcare.04042","article-title":"Aerosol Therapy During Non-invasive Ventilation or High-Flow Nasal Cannula","volume":"60","author":"Hess","year":"2015","journal-title":"Respiratory care"},{"issue":"Suppl 1","key":"10.1016\/j.ijtb.2022.06.004_bib551","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1089\/jam.2007.0574","article-title":"The mask for non-invasive ventilation: principles of design and effects on aerosol delivery","volume":"20","author":"Hess","year":"2007","journal-title":"J Aerosol Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib552","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jcrc.2008.12.009","article-title":"Effects of inhalational bronchodilator treatment during non-invasive ventilation in severe chronic obstructive pulmonary disease exacerbations","volume":"24","author":"Mukhopadhyay","year":"2009","journal-title":"Journal of critical care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib553","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.4187\/respcare.03667","article-title":"Radio aerosol pulmonary deposition using mesh and jet nebulizers during noninvasive ventilation in healthy subjects","volume":"60","author":"Galindo-Filho","year":"2015","journal-title":"Respir Care"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib554","first-page":"536","article-title":"Behera DA prospective randomized controlled trial on the efficacy of noninvasive ventilation in severe acute asthma","volume":"55","author":"Gupta","year":"2010","journal-title":"Respir Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib555","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/jamp.2016.1343","article-title":"Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth","volume":"30","author":"Walenga","year":"2017","journal-title":"J Aer Med Pulm Drug Del"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib556","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4187\/respcare.02518","article-title":"Nebulization During Spontaneous Breathing, CPAP, and Bi-Level Positive-Pressure Ventilation: A Randomized Analysis of Pulmonary Radioaerosol Deposition","volume":"59","author":"Maccari","year":"2014","journal-title":"Respiratory care"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib557","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0196-0644(95)70003-X","article-title":"Treatment of acute bronchospasm with beta-adrenergic agonist aerosols delivered by a nasal bilevel positive airway pressure circuit","volume":"26","author":"Pollack","year":"1995","journal-title":"Ann Emerg. Med."},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib135","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/02770900902718829","article-title":"Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma","volume":"46","author":"Brandao","year":"2009","journal-title":"The Journal of asthma : official journal of the Association for the Care of Asthma"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib559","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4187\/respcare.01371","article-title":"Non-invasive ventilation coupled with nebulization during asthma crises: a randomized controlled trial","volume":"58","author":"Galindo-Filho","year":"2013","journal-title":"Respiratory care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib560","article-title":"Inhalation Techniques Used in Patients with Respiratory Failure Treated with Non-invasive Mechanical Ventilation","author":"Rzepka-Wrona","year":"2018","journal-title":"Canadian Respir. Jr"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib561","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.2042-7158.2010.01134.x","article-title":"In-vitro characterisation of the nebulised dose during non-invasive ventilation","volume":"62","author":"Abdelrahim","year":"2010","journal-title":"The Journal of pharmacy and pharmacology"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib562","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1097\/00003246-200211000-00018","article-title":"In\u00a0vitro evaluation of aerosol bronchodilator delivery during non-invasive positive pressure ventilation: effect of ventilator settings and nebulizer position","volume":"30","author":"Chatmongkolchart","year":"2002","journal-title":"Critical care medicine"},{"issue":"suppl 61","key":"10.1016\/j.ijtb.2022.06.004_bib563","first-page":"PA1894","article-title":"Comparison of response to aerosol drug delivery with mesh and jet nebulizers during non-invasive ventilation (NIV) in acute exacerbation of COPD","volume":"50","author":"Avdeev","year":"2017","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib564","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jamp.2011.0929","article-title":"Dhand RJ Aerosol therapy in patients receiving non-invasive positive pressure ventilation","volume":"25","year":"2012","journal-title":"Aerosol Med Pulm Drug Deliv"},{"issue":"13","key":"10.1016\/j.ijtb.2022.06.004_bib565","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s40265-017-0787-0","article-title":"Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects","volume":"77","author":"Poulakou","year":"2017","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib566","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1378\/chest.130.5.1346","article-title":"An outbreak of Burkholderia cepacia associated with contamination of albuterol and nasal spray","volume":"130","author":"Estivariz","year":"2006","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib567","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4187\/respcare.03513","article-title":"Device Cleaning and Infection Control in Aerosol Therapy","volume":"60","author":"O'Malley","year":"2015","journal-title":"Respir Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib568","series-title":"Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities","author":"Rutala","year":"2008"},{"issue":"Suppl 1","key":"10.1016\/j.ijtb.2022.06.004_bib569","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/676882","article-title":"Infection prevention and control guideline for cystic fibrosis: 2013 update","volume":"35","author":"Saiman","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib570","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1378\/chest.114.2.577","article-title":"Effects of repetitive use and cleaning techniques of disposable jet nebulizers on aerosol generation","volume":"114","author":"Standaert","year":"1998","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib571","first-page":"258","article-title":"A day in the life of a nebulizer: surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting","volume":"52","author":"O'Malley","year":"2007","journal-title":"Respir Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib572","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1183\/09031936.01.00220001","article-title":"European Respiratory Society Guidelines on the use of nebulizers","volume":"18","author":"Boe","year":"2001","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib573","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1183\/13993003\/erj.18.5.758","article-title":"GENebu Project: home nebulizer use and maintenance in Italy","volume":"18","author":"Melani","year":"2001","journal-title":"Eur Respir J"},{"issue":"18","key":"10.1016\/j.ijtb.2022.06.004_bib574","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.2146\/ajhp060015","article-title":"Unlabeled uses of nebulized medications","volume":"63","author":"Shirk","year":"2006","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib575","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMe020070","article-title":"What is cystic fibrosis?","volume":"347","author":"Knowles","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib576","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/INF.0000000000000714","article-title":"Increased prevalence and resistance of important pathogens recovered from respiratory specimens of cystic fibrosis patients during a decade","volume":"34","author":"Raidt","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib577","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1513\/AnnalsATS.201402-050AS","article-title":"Antibiotic management of lung infections in cystic fibrosis-I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections","volume":"11","author":"Chmiel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib578","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"Doring","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib579","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee","year":"2003","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcf.2012.07.008","article-title":"Van daele S, Deseyne S, De Baets F. Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis, not chronically colonized by P. aeruginosa","volume":"12","author":"Schelstraete","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ijtb.2022.06.004_bib581","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/PPA.S53653","article-title":"Inhaled antibiotics for the treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients: challenges to treatment adherence and strategies to improve outcomes","volume":"10","author":"Bodn\u00e1r","year":"2016","journal-title":"Patient Prefer Adherence"},{"issue":"14","key":"10.1016\/j.ijtb.2022.06.004_bib582","first-page":"364","article-title":"Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis","volume":"1","author":"Smith","year":"2017","journal-title":"FEMS Microbiol Lett"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib583","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/ppul.23519","article-title":"Eradication of methicillin resistant Staphylococcus aureus detected for the first time in cystic fibrosis: A single center observational study","volume":"51","author":"Kappler","year":"2016","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib584","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/CMR.00101-15","article-title":"Inhaled Antibiotics for Gram-Negative Respiratory Infections","volume":"29","author":"Wenzler","year":"2016","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib585","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4187\/respcare.04208","article-title":"Aerosolized Antibiotics","volume":"60","author":"Restrepo","year":"2015","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib586","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1586\/17476348.2014.896205","article-title":"Aerosolized antibiotics in cystic fibrosis: an update","volume":"8","author":"Fiel","year":"2014","journal-title":"Expert Rev Respir Med"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib587","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4103\/lungindia.lungindia_39_17","article-title":"The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics","volume":"34","author":"Abdul Wahab","year":"2017","journal-title":"Lung India"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib588","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2018-000348","article-title":"British Thoracic Society guideline for bronchiectasis in adults","volume":"5","author":"Hill","year":"2018","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.ijtb.2022.06.004_bib589","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/17476348.2018.1500179","article-title":"The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis","volume":"12","author":"Amaro","year":"2018","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib590","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"149","key":"10.1016\/j.ijtb.2022.06.004_bib591","doi-asserted-by":"crossref","first-page":"180016","DOI":"10.1183\/16000617.0016-2018","article-title":"Bronchiectasis: a case-based approach to investigation and management","volume":"27","author":"Contarini","year":"2018","journal-title":"Eur Respir Rev."},{"key":"10.1016\/j.ijtb.2022.06.004_bib592","doi-asserted-by":"crossref","first-page":"1600851","DOI":"10.1183\/13993003.00851-2016","article-title":"Efficacy of pseudomonas aeruginosa eradication regimens in bronchiectasis","volume":"49","author":"Vallieres","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib593","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1183\/09031936.00018414","article-title":"Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review","volume":"44","author":"Brodt","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib594","article-title":"Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis","volume":"4","author":"Langton Hewer","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib595","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/cid\/civ377","article-title":"Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis","volume":"61","author":"Mayer-Hamblett","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib596","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","article-title":"Cystic Fibrosis Foundation Pulmonary Guideline. Pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection","volume":"11","author":"Mogayzel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ijtb.2022.06.004_bib597","article-title":"Inhaled anti-pseudomonas antibiotics for long-term therapy in cystic fibrosis","volume":"3","author":"Smith","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijtb.2022.06.004_bib598","article-title":"Interventions for eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with Cystic Fibrosis","volume":"7","author":"Lo","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib599","article-title":"Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis","volume":"7","author":"Ahmed","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"issue":"10 Suppl","key":"10.1016\/j.ijtb.2022.06.004_bib600","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S1569-1993(11)60012-X","article-title":"Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the Euro-Care CF Working Group on outcome parameters in clinical trials","volume":"2","author":"Bilton","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ijtb.2022.06.004_bib601","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1183\/09059180.00006512","article-title":"Treatment of pulmonary exacerbations in cystic fibrosis","volume":"22","author":"Bhatt","year":"2013","journal-title":"European Respiratory Review"},{"key":"10.1016\/j.ijtb.2022.06.004_bib602","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib603","article-title":"Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis","volume":"12","author":"Ryan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib604","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/jamp.2013.1055","article-title":"Nebulized Tobramycin in the treatment of adult CF pulmonary exacerbations","volume":"27","author":"Al-Aloul","year":"2014","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib605","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcf.2017.04.005","article-title":"Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations","volume":"16","author":"Sanders","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ijtb.2022.06.004_bib606","article-title":"Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis","volume":"10","author":"Smith","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijtb.2022.06.004_bib607","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled Tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib608","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000486134","article-title":"A Prospective Trial of Nebulized Amikacin in the Treatment of Bronchiectasis Exacerbation","volume":"95","author":"Ailiyaer","year":"2018","journal-title":"Respiration"},{"key":"10.1016\/j.ijtb.2022.06.004_bib609","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled Tobramycin in patients with cystic fibrosis. Cystic Fibrosis inhaled Tobramycin Study Group","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib610","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ppul.20097","article-title":"Treatment with Tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease","volume":"38","author":"Murphy","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib611","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/ppul.21301","article-title":"An 18-month study of the safety and efficacy of repeated courses of inhaled Aztreonam lysine in cystic fibrosis","volume":"45","author":"Oermann","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib612","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1164\/rccm.200712-1804OC","article-title":"Inhaled Aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis","volume":"178","author":"McCoy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib613","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1060028015621916","article-title":"New Inhaled Antimicrobial Formulations for Use in the Cystic Fibrosis Patient Population","volume":"50","author":"Campbell","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijtb.2022.06.004_bib614","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/thx.51.4.364","article-title":"Nebulized anti-pseudomonas antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks","volume":"51","author":"Mukhopadhyay","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib615","first-page":"227","article-title":"Phase II blinded and placebo-controlled studies of nebulized liposomal Amikacin for inhalation (Arikace) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection","volume":"33","author":"Clancy","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib616","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1164\/rccm.201008-1293OC","article-title":"Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa","volume":"183","author":"Geller","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib617","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jamp.2013.1056","article-title":"Safety and pharmacokinetics of ciprofloxacin dry powder for inhalation in cystic fibrosis: a phase I, randomized, single-dose, dose-escalation study","volume":"28","author":"Stass","year":"2015","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib618","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcf.2010.10.003","article-title":"Safety, efficacy and convenience of Tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial","volume":"10","author":"Konstan","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib619","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1753465817710596","article-title":"Ease of use of Tobramycin inhalation powder compared with nebulized Tobramycin and Colistimethate sodium: a crossover study in cystic fibrosis with pulmonary Pseudomonas aeruginosa infection","volume":"11","author":"Greenwood","year":"2017","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib620","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0954-6111(99)90090-2","article-title":"Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa","volume":"93","author":"Orriols","year":"1999","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib621","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomized double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib622","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1183\/09031936.00071312","article-title":"Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomized study","volume":"41","author":"Wilson","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib623","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/thoraxjnl-2013-203207","article-title":"Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomized, double-blind, placebo-controlled trial","volume":"68","author":"Serisier","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib624","doi-asserted-by":"crossref","first-page":"1702052","DOI":"10.1183\/13993003.02052-2017","article-title":"RESPIRE 1: a phase III placebo-controlled randomized trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"De Soyza","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib625","doi-asserted-by":"crossref","first-page":"1702053","DOI":"10.1183\/13993003.02053-2017","article-title":"RESPIRE 2: a phase III placebo-controlled randomized trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"Aksamit","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib626","doi-asserted-by":"crossref","first-page":"S3428","DOI":"10.21037\/jtd.2018.09.39","article-title":"Medical management of bronchiectasis","volume":"10","author":"O'Donnell","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib627","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201005-0756OC","article-title":"A randomized controlled trial of nebulized Gentamycin in non-cystic fibrosis bronchiectasis","volume":"183","author":"Murray","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib628","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","article-title":"Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib629","doi-asserted-by":"crossref","first-page":"114S","DOI":"10.1378\/chest.120.3_suppl.114S","article-title":"Treatment with Tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa","volume":"120","author":"Couch","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib630","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1345\/aph.1E099","article-title":"Inhaled Tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa","volume":"39","author":"Drobnic","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijtb.2022.06.004_bib631","first-page":"1420","article-title":"A pilot study of the safety and efficacy of Tobramycin solution for inhalation in patients with severe bronchiectasis","volume":"127","author":"Scheinberg","year":"2005","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib632","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.regg.2014.09.005","article-title":"Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection","volume":"50","author":"Tabernero Huguet","year":"2015","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib633","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1445-5994.2007.01404.x","article-title":"Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis","volume":"37","author":"Steinfort","year":"2007","journal-title":"Intern Med J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib634","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/thx.2008.112284","article-title":"Efficacy of nebulized colomycin in patients with non-cystic fibrosis bronchiectasis colonized with Pseudomonas aeruginosa","volume":"65","author":"Dhar","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib635","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection","volume":"189","author":"Haworth","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib636","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0954-6111(11)70022-1","article-title":"Aerosolized antibiotic therapy for chronic cystic fibrosis airway infections: continuous or intermittent?","volume":"105","author":"Lo","year":"2011","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib637","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.arbr.2014.05.014","article-title":"Nebulized therapy. SEPAR year","volume":"50","author":"Olveira","year":"2014","journal-title":"Archivos de bronconeumologia"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib638","article-title":"Interventions for bronchiectasis: an overview of Cochrane systematic reviews","author":"Welsh","year":"2015","journal-title":"Respirology (Carlton, Vic)"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib639","first-page":"180","article-title":"The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration","volume":"13","author":"Marshall","year":"2017","journal-title":"The European respiratory journal"},{"key":"10.1016\/j.ijtb.2022.06.004_bib640","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2147\/CIA.S143139","article-title":"Non-cystic fibrosis bronchiectasis in the elderly: current perspectives","volume":"13","author":"Quinn","year":"2018","journal-title":"Clinical interventions in aging"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib641","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.rppneu.2013.03.006","article-title":"New advances in the therapy of non-cystic fibrosis bronchiectasis","volume":"19","author":"Amorim","year":"2013","journal-title":"Revista portuguesa de pneumologia"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib642","first-page":"S66","article-title":"Hypertonic saline X recombinant human DNase: a randomised cross-over study in 18 cystic fibrosis patients","volume":"3","author":"Adde","year":"2004","journal-title":"Journal of Cystic Fibrosis"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib643","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1183\/09031936.00072510","article-title":"The effect of dornase alfa on ventilation in homogeneity in patients with cystic fibrosis","volume":"37","author":"Amin","year":"2011","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.ijtb.2022.06.004_bib644","article-title":"Dornase alfa for cystic fibrosis","volume":"9","author":"Yang","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ijtb.2022.06.004_bib645","article-title":"Nebulised hypertonic saline for cystic fibrosis","volume":"9","author":"Wark","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ijtb.2022.06.004_bib646","article-title":"Inhaled mannitol for cystic fibrosis","volume":"2","author":"Nevitt","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib647","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1569-1993(01)00009-1","article-title":"Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis","volume":"1","author":"Ballmann","year":"2002","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib648","first-page":"246","article-title":"Effect of aerosolised or rhDNase (Pulmozyme) on pulmonary infections in CF: an open randomised study","volume":"20","author":"Frederiksen","year":"2000","journal-title":"Pediatric Pulmonology"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib649","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/S1569-1993(12)60216-1","article-title":"Bronchitol (inhaled dry powder mannitol) in adult patients with cystic fibrosis","volume":"11","author":"Aitken","year":"2012","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib650","series-title":"A randomized, blinded, controlled, crossover study of inhaled, dry powder mannitol (bronchitol) in CF: Proceedings of American Thoracic Society Conference","author":"Charlton","year":"2006"},{"key":"10.1016\/j.ijtb.2022.06.004_bib651","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcf.2010.08.020","article-title":"Inhaled mannitol in patients with cystic fibrosis: a randomised open-label dose response trial","volume":"10","author":"Teper","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib652","first-page":"A43","article-title":"Effect of hypertonic saline, isotonic saline and water challenges on the airways of cystic fibrosis patients","volume":"52","author":"Chadwick","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib653","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib654","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1378\/chest.110.4.889","article-title":"Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease","volume":"110","author":"McCoy","year":"1996","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib655","article-title":"Mucolytics for bronchiectasis","author":"Wilkinson","year":"2014","journal-title":"The Cochrane database of systematic reviews"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib656","first-page":"1084","volume":"22","author":"Tarrant","year":"2017","journal-title":"Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib657","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1164\/ajrccm.153.2.8564129","article-title":"Effect of rhDNAse on airflow obstruction and muco-ciliary clearance in cystic fibrosis","volume":"153","author":"Laube","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib658","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1164\/ajrccm\/148.1.145","article-title":"Efficacy and safety of short-term administration of aerosolized recombinant human deoxy-ribonuclease in patients with cystic fibrosis","volume":"148","author":"Ramsey","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib659","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0140-6736(93)92297-7","article-title":"Efficacy and safety of short-term administration of aerosolized recombinant human DNase I in adults with stable stage cystic fibrosis","volume":"342","author":"Ranasinha","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ijtb.2022.06.004_bib660","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/thx.51.2.119","article-title":"In\u00a0vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis","volume":"51","author":"Shah","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib661","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1164\/ajrccm.153.6.8665055","article-title":"Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations","volume":"153","author":"Wilmott","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib662","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1183\/09031936.97.10112449","article-title":"Inhalation of dry powder mannitol increases muco-ciliary clearance","volume":"10","author":"Daviskas","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib663","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1034\/j.1399-3003.1999.14c30.x","article-title":"The effect of inhaled mannitol on bronchial mucus clearance in CF patients: a pilot study","volume":"14","author":"Robinson","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib664","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcf.2012.11.002","article-title":"Pooled analysis of two large randomized phase-3 inhaled mannitol studies in cystic fibrosis","volume":"12","author":"Bilton","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ijtb.2022.06.004_bib665","article-title":"Inhaled mannitol for cystic fibrosis","volume":"10","author":"Nolan","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ijtb.2022.06.004_bib666","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ppul.1950200205","article-title":"Combined effects of hypertonic saline and rhDNAse on cystic fibrosis sputum in\u00a0vitro","volume":"20","author":"Dasgupta","year":"1995","journal-title":"Pediatr pulmonol"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib667","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib668","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1164\/ajrccm.154.2.8756815","article-title":"Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in\u00a0vitro sputum transportability","volume":"154","author":"Wills","year":"1996","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib669","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group","volume":"113","author":"O'Donnell","year":"1998","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib670","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1378\/chest.12-1763","article-title":"Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis","volume":"144","author":"Bilton","year":"2013","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib671","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/thoraxjnl-2014-205587","article-title":"Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial","volume":"69","author":"Bilton","year":"2014","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib672","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"Kellett","year":"2011","journal-title":"Respiratory medicine"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib673","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","article-title":"The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis","volume":"106","author":"Nicolson","year":"2012","journal-title":"Respiratory medicine"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib674","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jamp.2017.1443","article-title":"Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial","volume":"31","author":"Herrero-Cortina","year":"2018","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib675","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/13543784.2018.1427728","article-title":"Investigational inhaled therapies for non-CF bronchiectasis","volume":"27","author":"Antoniu","year":"2018","journal-title":"Expert opinion on investigational drugs"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib676","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"European heart journal"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib677","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4187\/respcare.03927","article-title":"Inhaled Therapies for Pulmonary Hypertension","volume":"60","author":"Hill","year":"2015","journal-title":"Respiratory care"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib678","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1592\/phco.30.7.728","article-title":"Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults","volume":"30","author":"Buckley","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"138","key":"10.1016\/j.ijtb.2022.06.004_bib679","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1183\/16000617.0067-2015","article-title":"Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension. European respiratory review","volume":"24","author":"Lang","year":"2015","journal-title":"an official journal of the European Respiratory Society"},{"issue":"7-8","key":"10.1016\/j.ijtb.2022.06.004_bib680","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1345\/aph.1E575","article-title":"Inhaled iloprost in pulmonary arterial hypertension","volume":"39","author":"Baker","year":"2005","journal-title":"The Annals of pharmacotherapy"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib681","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/VHRM.S3223","article-title":"Inhaled iloprost for the control of pulmonary hypertension","volume":"5","author":"Krug","year":"2009","journal-title":"Vascular health and risk management"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib682","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"The New England journal of medicine"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib683","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1183\/09031936.06.00057906","article-title":"Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension","volume":"28","author":"Hoeper","year":"2006","journal-title":"The European respiratory journal"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib684","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200603-358OC","article-title":"Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension","volume":"174","author":"McLaughlin","year":"2006","journal-title":"American journal of respiratory and critical care medicine"},{"key":"10.1016\/j.ijtb.2022.06.004_bib685","article-title":"STEP-open label extension: long-term benefits of inhaled iloprost (ILO) addition to bosentan for treatment of pulmonary arterial hypertension","volume":"175","year":"2007","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib686","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/clc.21987","article-title":"Inhaled low-dose iloprost for pulmonary hypertension: a prospective, multicenter, open-label study","volume":"35","author":"Sun","year":"2012","journal-title":"Clinical cardiology"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib687","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pupt.2010.06.004","article-title":"Intravenous epoprostenol versus high dose inhaled iloprost for long-term treatment of pulmonary hypertension","volume":"24","author":"Reichenberger","year":"2011","journal-title":"Pulmonary pharmacology & therapeutics"},{"key":"10.1016\/j.ijtb.2022.06.004_bib688","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/DDDT.S19281","article-title":"Inhaled treprostinil: a therapeutic review","volume":"6","author":"Channick","year":"2012","journal-title":"Drug design, development and therapy"},{"issue":"18","key":"10.1016\/j.ijtb.2022.06.004_bib689","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib690","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/erc.12.160","article-title":"Treprostinil for the treatment of pulmonary arterial hypertension","volume":"11","author":"Torres","year":"2013","journal-title":"Expert review of cardiovascular therapy"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib691","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s40262-016-0409-0","article-title":"A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration","volume":"55","author":"Kumar","year":"2016","journal-title":"Clinical pharmacokinetics"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib692","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/FJC.0000000000000357","article-title":"Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension","volume":"67","author":"Parikh","year":"2016","journal-title":"Journal of cardiovascular pharmacology"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib693","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.healun.2011.08.019","article-title":"Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension","volume":"30","author":"Benza","year":"2011","journal-title":"The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib694","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.amjcard.2012.07.012","article-title":"Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension","volume":"110","author":"de Jesus Perez","year":"2012","journal-title":"The American journal of cardiology"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib695","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1755-5922.12008","article-title":"Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension","volume":"31","author":"Bourge","year":"2013","journal-title":"Cardiovascular therapeutics"},{"key":"10.1016\/j.ijtb.2022.06.004_bib696","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1477-7525-11-31","article-title":"Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension","volume":"11","author":"Chen","year":"2013","journal-title":"Health and quality of life outcomes"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib697","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jcpt.12170","article-title":"Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series","volume":"39","author":"Enderby","year":"2014","journal-title":"Journal of clinical pharmacy and therapeutics"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib698","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/677360","article-title":"Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertension","volume":"4","author":"Preston","year":"2014","journal-title":"Pulmonary circulation"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib699","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0897190017703507","article-title":"Transition From Subcutaneous or Inhaled Treprostinil to Oral Treprostinil at Home in Patients With Pulmonary Arterial Hypertension: A Retrospective Case Series","volume":"31","author":"Ackerbauer","year":"2018","journal-title":"Journal of pharmacy practice"},{"key":"10.1016\/j.ijtb.2022.06.004_bib700","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pupt.2016.07.007","article-title":"Transitioning from parenteral to inhaled prostacyclin therapy in pulmonary arterial hypertension","volume":"40","author":"Ataya","year":"2016","journal-title":"Pulmonary pharmacology & therapeutics"},{"key":"10.1016\/j.ijtb.2022.06.004_bib701","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0012-3692(15)52214-9","article-title":"Nebulized Lidocaine for Flexible Bronchoscopy: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"128","author":"Stolz","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib702","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/thx.2003.019836","article-title":"Cough suppression during flexible bronchoscopy using combined sedation with midazolam and hydrocodone: a randomised, double blind, placebo controlled trial","volume":"59","author":"Stolz","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib703","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2044.1990.tb14504.x","article-title":"A jet nebuliser for delivery of topical anaesthesia to the respiratory tract: a comparison with cricothyroid punctures and directs spraying for fibreoptic bronchoscopy","volume":"45","author":"Isaac","year":"1990","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ijtb.2022.06.004_bib704","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1164\/ajrccm\/146.2.520","article-title":"Aerosolized lidocaine reduces dose of topical anaesthetic for bronchoscopy","volume":"146","author":"Foster","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib705","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1183\/09031936.93.05091123","article-title":"Comparison of nebulized and sprayed topical anaesthesia for fibreoptic bronchoscopy","volume":"5","author":"Keane","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib706","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1054\/cupe.2001.0242","article-title":"Amore AD,Hewsons GC.The management of acute upper airway obstruction in children","volume":"12","year":"2002","journal-title":"Current Paediatrics"},{"key":"10.1016\/j.ijtb.2022.06.004_bib707","first-page":"553","article-title":"Comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup","volume":"20","author":"Johnson","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib708","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0031-3955(05)70180-2","article-title":"Croup: A current perspective","volume":"46","author":"Klassen","year":"1999","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.ijtb.2022.06.004_bib709","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijporl.2003.11.017","article-title":"A comparison of nebulized budesonide, intramuscular, and oral dexamethasone for treatment of croup","volume":"68","author":"Cetinkaya","year":"2004","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib710","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1183\/18106838.0204.332","article-title":"Croup: diagnosis and treatment","volume":"2","author":"Canciani","year":"2006","journal-title":"Breathe"},{"key":"10.1016\/j.ijtb.2022.06.004_bib711","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0196-0644(96)70084-7","article-title":"Sixteen years of croup in a Western Australian teaching hospital: the impact of routine steroid therapy","volume":"28","author":"Geelhoed","year":"1996","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib712","first-page":"16","article-title":"Intramuscular versus oral dexamethasone for the treatment of moderate-to severe croup: a randomized, double-blind trial","volume":"10","author":"Donaldson","year":"2003","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib713","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/bmj.319.7210.595","article-title":"The effectiveness of glucocorticoids in treating croup: meta-analysis","volume":"319","author":"Ausejo","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ijtb.2022.06.004_bib714","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/adc.68.3.352","article-title":"Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study","volume":"68","author":"Husby","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ijtb.2022.06.004_bib715","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0733-8627(03)00053-1","article-title":"New approaches to respiratory infections in children: Bronchiolitis and croup","volume":"20","author":"Wright","year":"2002","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.ijtb.2022.06.004_bib716","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2044.1995.tb04510.x","article-title":"Adrenaline administered via a nebulizer in adult patients with upper airway obstruction","volume":"50","author":"Macdonnell","year":"1995","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ijtb.2022.06.004_bib717","first-page":"S18","article-title":"Efficacy of L-epinephrine and beclomethasone aerosol in croup","volume":"7","author":"Canciani","year":"1994","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib718","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.97.5.722","article-title":"Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup","volume":"97","author":"Fitzgerald","year":"1996","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib719","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1513\/AnnalsATS.201311-395FR","article-title":"Inhaled antibiotics for lower airway infections","volume":"11","author":"Quon","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ijtb.2022.06.004_bib720","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1086\/504486","article-title":"Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species","volume":"43","author":"Rahal","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib721","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/02652049309015314","article-title":"Disposition of liposomal Gentamycin following intrabronchial administration in rabbits","volume":"10","author":"Demaeyer","year":"1993","journal-title":"J Microencapsul"},{"key":"10.1016\/j.ijtb.2022.06.004_bib722","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00000542-200207000-00028","article-title":"Experimental ICU Study Group In\ufb02uence of lung aeration on pulmonary concentrations of nebulized and intravenous Amikacin in ventilated piglets with severe bronchopneumonia","volume":"97","author":"Elman","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijtb.2022.06.004_bib723","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1128\/AAC.00268-09","article-title":"Efficacy of aerosol MP-376, Levo\ufb02oxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa","volume":"53","author":"Sabet","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib724","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ijantimicag.2015.09.011","article-title":"Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis","volume":"46","author":"Liu","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib725","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/QCO.0000000000000004","article-title":"Aerosolized antibiotics: do they add to the treatment of pneumonia?","volume":"26","author":"Kollef","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib726","first-page":"478","article-title":"Aerosol therapy for lung abscess","volume":"62","author":"Hristie","year":"1950","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib727","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tube.2010.08.009","article-title":"Inhaled drug therapy for treatment of tuberculosis","volume":"91","author":"Misra","year":"2011","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib728","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0033-1333575","article-title":"Management of non-tuberculous mycobacterial (NTM) lung disease","volume":"34","author":"Philley","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib729","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1023\/A:1007527204887","article-title":"Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization","volume":"17","author":"O\u2019Hara","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.ijtb.2022.06.004_bib730","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejps.2007.06.006","article-title":"Inhalable micro particles containing large payload of anti-tuberculosis drugs","volume":"32","author":"Muttil","year":"2007","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ijtb.2022.06.004_bib731","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2005.12.031","article-title":"Development of liposomal capreomycin sulfate formulations: effects of formulation variables on peptide encapsulation","volume":"311","author":"Ricci","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ijtb.2022.06.004_bib732","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1513\/AnnalsATS.201307-231OC","article-title":"Inhaled Amikacin for treatment of refractory pulmonary non-tuberculous mycobacterial disease","volume":"11","author":"Olivier","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ijtb.2022.06.004_bib733","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/0022-3859.41823","article-title":"Low-dose inhaled versus standard dose oral form of anti-tubercular drugs: concentrations in bronchial epithelial lining fluid, alveolar macrophage and serum","volume":"54","author":"Katiyar","year":"2008","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib734","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2466-7-2","article-title":"Aerosolized Amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series","volume":"7","author":"Davis","year":"2007","journal-title":"BMC Pulmon Med"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib735","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s10096-011-1516-3","article-title":"Aerosolized Amikacin in patients with difficult-to-treat pulmonary non-tuberculous mycobacteriosis","volume":"31","author":"Safdar","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib736","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s12879-017-2665-5","article-title":"The efficacy, safety, and feasibility of inhaled Amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases","volume":"17","author":"Yagi","year":"2017","journal-title":"BMC infectious diseases"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib737","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.201604-0700OC","article-title":"Randomized Trial of Liposomal Amikacin for Inhalation in non-tuberculous Mycobacterial Lung Disease","volume":"195","author":"Olivier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib738","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","article-title":"US Cystic fibrosis foundation and European cystic fibrosis society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib739","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1741-7015-10-104","article-title":"New treatments for influenza","volume":"10","author":"Barik","year":"2012","journal-title":"BMC Medicine"},{"key":"10.1016\/j.ijtb.2022.06.004_bib740","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00006454-198702000-00003","article-title":"Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic","volume":"6","author":"Conrad","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib741","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1542\/peds.79.3.475","article-title":"Ribavirin therapy of respiratory syncytial virus","volume":"79","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijtb.2022.06.004_bib742","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.34.4.668","article-title":"Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections","volume":"34","author":"Bradley","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijtb.2022.06.004_bib743","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"Von Itzstein","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ijtb.2022.06.004_bib744","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.1232552","article-title":"Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity","volume":"340","author":"Kim","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ijtb.2022.06.004_bib745","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.clinthera.2007.08.023","article-title":"Efficacy and safety of inhaled Zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial","volume":"29","author":"LaForce","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijtb.2022.06.004_bib746","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/314904","article-title":"Efficacy and safety of the neuraminidase inhibitor Zanamivir in the treatment of influenza A and B virus infections","volume":"180","author":"Monto","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib747","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/AAC.44.7.1974-1976.2000","article-title":"Direct measurement of the anti-influenza agent Zanamivir in the respiratory tract following inhalation","volume":"44","author":"Peng","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijtb.2022.06.004_bib748","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1086\/315392","article-title":"Rapid antiviral effect of inhaled Zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults","volume":"181","author":"Boivin","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib749","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJM200003023420914","article-title":"Respiratory distress associated with Zanamivir","volume":"342","author":"Williamson","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib750","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jinf.2007.09.002","article-title":"A comparison of the effectiveness of Zanamivir and Oseltamivir for the treatment of influenza A and B","volume":"56","author":"Kawai","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.ijtb.2022.06.004_bib751","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1086\/650176","article-title":"Fatal respiratory events caused by Zanamivir nebulization","volume":"50","author":"Kiatboonsri","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib752","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/eri.11.112","article-title":"Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza","volume":"9","author":"Ikematsu","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijtb.2022.06.004_bib753","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1128\/AAC.01755-09","article-title":"Long-acting neuraminidase inhibitor Laninamivir octanoate versus Oseltamivir as treatment for children with influenza virus infection","volume":"54","author":"Sugaya","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijtb.2022.06.004_bib754","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.ijtb.2022.06.004_bib755","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM199009203231201","article-title":"Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial","volume":"323","author":"Leoung","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib756","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1378\/chest.95.4.747","article-title":"Aerosolized pentamidine as second line therapy in patients with AIDS and Pneumocystis carinii pneumonia","volume":"95","author":"Montgomery","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib757","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/clinids\/20.3.531","article-title":"Once-weekly administration of dapsone\/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients","volume":"20","author":"Opravil","year":"1995","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.ijtb.2022.06.004_bib758","doi-asserted-by":"crossref","first-page":"177e88","DOI":"10.1001\/archinte.1996.00440020081010","article-title":"A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens","volume":"156","author":"Ioannidis","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib759","first-page":"1853e60","article-title":"Prevention and treatment of Pneumocystis carinii pneumonia","volume":"327","author":"Masur","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib760","doi-asserted-by":"crossref","first-page":"625e34","DOI":"10.1093\/clinids\/7.5.625","article-title":"Pentamidine: a review","volume":"7","author":"Sands","year":"1985","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib761","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJM199212243272603","article-title":"A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group","volume":"327","author":"Schneider","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib762","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1399-3062.2007.00209.x","article-title":"Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study","volume":"9","author":"Lowry","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib763","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/tri.12679","article-title":"10 years prophylaxis with nebulized liposomal amphotericin-B and the changing epidemiology of Aspergillus spp. Infection in lung transplantation","volume":"29","author":"Peghin","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.ijtb.2022.06.004_bib764","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1211\/jpp.57.10.0007","article-title":"Nebulization of four commercially available amphotericin B formulations in persistently granulocytopenic rats with invasive pulmonary aspergillosis: evidence for long-term biological activity","volume":"57","author":"Ruijgrok","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib765","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1021\/js9604218","article-title":"Disposition of aerosolized liposomal amphotericin B","volume":"86","author":"Lambros","year":"1997","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib766","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/phar.1309","article-title":"Aerosolized amphotericin-B lipid complex as adjunctive treatment for fungal lung infection in patients with cancer-related immuno-suppression and recipients of hematopoietic stem cell transplantation","volume":"33","author":"Safdar","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijtb.2022.06.004_bib767","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/thx.54.11.1047","article-title":"Successful treatment of post-influenza pseudo-membranous necrotizing bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B gamma interferon and GM-CSF","volume":"54","author":"Boots","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib768","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1159\/000334189","article-title":"Palliative Care Concepts in Respiratory Disease","volume":"82","author":"Heigener","year":"2011","journal-title":"Respiration"},{"key":"10.1016\/j.ijtb.2022.06.004_bib769","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/bmj.315.7113.931","article-title":"ABC of palliative care: Breathlessness, cough, and other respiratory problems","volume":"315","author":"Davis","year":"1997","journal-title":"BMJ"},{"issue":"126","key":"10.1016\/j.ijtb.2022.06.004_bib770","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1183\/09059180.00001512","article-title":"Palliative care in COPD patients: is it only an end-of-life issue?","volume":"21","author":"Carlucci","year":"2012","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ijtb.2022.06.004_bib771","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1136\/thx.52.2008.S75","article-title":"Nebulized drugs in palliative care","volume":"52","author":"Ahmedzai","year":"1997","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib772","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1378\/chest.125.2.363","article-title":"Nebulized morphine: a convenient and safe alternative to dyspnea relief?","volume":"125","author":"Baydur","year":"2004","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib773","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1345\/aph.1E328","article-title":"Nebulized morphine for relief of dyspnea due to chronic lung disease","volume":"39","author":"Brown","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib774","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thorax.57.11.939","article-title":"A systematic review of the use of opioids in the management of dyspnoea","volume":"57","author":"Jennings","year":"2002","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib775","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpainsymman.2007.08.016","article-title":"Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline","volume":"36","author":"Charles","year":"2008","journal-title":"J Pain Symptom Manage"},{"issue":"14","key":"10.1016\/j.ijtb.2022.06.004_bib776","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2146\/ajhp150893","article-title":"Nebulized opioids for the palliation of dyspnea in terminally ill patients","volume":"74","author":"Afolabi","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib777","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12890-017-0535-y","article-title":"Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial","volume":"17","author":"Janowiak","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib778","article-title":"Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness","volume":"3","author":"Barnes","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib779","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jpainsymman.2007.10.017","article-title":"Nebulized furosemide for the management of dyspnea: does the evidence support its use?","volume":"36","author":"Newton","year":"2008","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib780","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1164\/rccm.200308-1171OC","article-title":"Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease","volume":"169","author":"Ong","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib781","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0885-3924(03)00322-1","article-title":"Effect of nebulized furosemide in terminally ill cancer patients with dyspnea","volume":"26","author":"Kohara","year":"2003","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib782","first-page":"900","article-title":"The role of inhaled opioids and furosemide for the treatment of dyspnea","volume":"52","author":"Kallet","year":"2007","journal-title":"Respir Care"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib783","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/emj.2004.015719","article-title":"Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease","volume":"22","author":"Chong","year":"2005","journal-title":"Emerg Med J"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib784","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/1049909112458577","article-title":"Nebulized lidocaine in treatment of intractable cough","volume":"30","author":"Truesdale","year":"2013","journal-title":"Am J Hosp Palliat Care"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib785","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1345\/aph.1R573","article-title":"Evidence for therapeutic uses of nebulized lidocaine in the treatment of intractable cough and asthma","volume":"47","author":"Slaton","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib786","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1378\/chest.12-1533","article-title":"Long-term safety of nebulized lidocaine for adults with difficult-to-control chronic cough: a case series","volume":"143","author":"Lim","year":"2013","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib787","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1089\/jpm.2015.0167","article-title":"Nebulized Tranexamic Acid as a Noninvasive Therapy for Cancer-Related Hemoptysis","volume":"18","author":"Hankerson","year":"2015","journal-title":"Journal of Palliative Medicine"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib788","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.chest.2018.09.026","article-title":"Inhaled Tranexamic Acid for Hemoptysis Treatment","volume":"154","author":"Wand","year":"2018","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib789","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0954-6111(06)80202-7","article-title":"Home nebulized therapy\u2014is it effective?","volume":"85","author":"O'Driscoll RJRm","year":"1991","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib790","series-title":"Inhaled therapy in elderly COPD patients; time for re-evaluation?","author":"Jarvis","year":"2007"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib791","first-page":"1360","article-title":"Problems with inhaler use: a call for improved clinician and patient education","volume":"50","author":"Fink","year":"2005","journal-title":"Respir Care"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib792","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0954-6111(96)90149-3","article-title":"A long-term study of symptoms, spirometry and survival amongst home nebulizer users","volume":"90","author":"O'driscoll","year":"1996","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib793","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1378\/chest.109.3.814","article-title":"Guidelines for the Use of Nebulizers in the Home and at Domiciliary Sites: Report of a Consensus Conference","volume":"109","author":"O'Donohue","year":"1996","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib794","first-page":"60","article-title":"Consensus Document on Home Nebulization for Maintenance Treatment of Obstructive Airway Diseases: A Joint Initiative by the National Allergy Asthma Bronchitis Institute (NAABI) and Chest Research Foundation (CRF)","volume":"65","author":"Ghoshal","year":"2017","journal-title":"J Assoc Phys India"},{"key":"10.1016\/j.ijtb.2022.06.004_bib795","series-title":"Guidelines for Use of Nebuliser Systems in the Home Environment","year":"2017"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib796","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1183\/09031936.01.00220001","article-title":"European Respiratory Society Guidelines on the use of nebulizers: Guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers","volume":"18","author":"Boe","year":"2001","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib797","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1513\/AnnalsATS.201311-395FR","article-title":"Inhaled antibiotics for lower airway infections","volume":"11","author":"Quon","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib798","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"Suppl 2","key":"10.1016\/j.ijtb.2022.06.004_bib799","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib800","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1183\/09031936.94.07091721","article-title":"Home treatment for chronic respiratory insufficiency: the situation in Europe in 1992. The European Working Group on Home Treatment for Chronic Respiratory Insufficiency","volume":"7","author":"Fauroux","year":"1994","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib804","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ageing\/24.4.276","article-title":"Community survey of home nebulizer technique by elderly people","volume":"24","author":"Teale","year":"1995","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib805","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2013-000018","article-title":"Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease","volume":"1","author":"Jarvis","year":"2014","journal-title":"BMJ open respiratory research"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib806","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.rmed.2005.03.004","article-title":"How do patients use their nebuliser in the community?","volume":"99","author":"Boyter","year":"2005","journal-title":"Respir Med"},{"issue":"Suppl 2","key":"10.1016\/j.ijtb.2022.06.004_bib807","first-page":"S4","article-title":"Nebulizer therapy. Guidelines. British Thoracic Society Nebulizer Project Group","volume":"52","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2022.06.004_bib809a","unstructured":"Home Nebulizer. Available from: https:\/\/my.clevelandclinic.org\/health\/drugs\/4254-home-nebulizer."},{"key":"10.1016\/j.ijtb.2022.06.004_bib809","series-title":"Nebulizer with a Mask","year":"2015"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib810","first-page":"58","article-title":"The cleaning and disinfection of nebulizers used at home and in a cystic fibrosis centre","volume":"6","author":"Le Brun","year":"2000","journal-title":"EHP-AMERONGEN-"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib811","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2014-000076","article-title":"Patients\u2019 practices and experiences of using nebuliser therapy in the management of COPD at home","volume":"2","author":"Alhaddad","year":"2015","journal-title":"BMJ Open Respir Res"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib812","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/003693309804300207","article-title":"Domiciliary Nebuliser Therapy\u2014A Valuable Option in Chronic Asthma and Chronic Obstructive Pulmonary Disease?","volume":"43","author":"Godden","year":"1998","journal-title":"Scott Med J"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib813","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0954-6111(06)80145-9","article-title":"Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy","volume":"86","author":"Goldman","year":"1992","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib947","doi-asserted-by":"crossref","unstructured":"Barbara R, Luciana de Freitas VM, Agnaldo J L, Luiz Vicente RF da S-F, Neiva D, Evanirso da SA, Paulo Jose CM, Jos\u00e9 DR. Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem. J. Bras. Pneumol. 45 (3) : 2019","DOI":"10.1590\/1806-3713\/e20170351"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib815","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0022-3476(87)80069-0","article-title":"Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment","volume":"111","author":"Pitchford","year":"1987","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib816","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2214.2006.00669.x","article-title":"Microbial contamination of nebulizers in the home treatment of cystic fibrosis","volume":"33","author":"Blau","year":"2007","journal-title":"Child Care Health Dev"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib817","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1590\/S1806-37132011000300010","article-title":"Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?","volume":"37","author":"Brzezinski","year":"2011","journal-title":"J Bras Pneumol"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib818","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3476(98)70497-4","article-title":"Home nebulizer use among patients with cystic fibrosis","volume":"132","author":"Rosenfeld","year":"1998","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib819","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1067\/mic.2000.110214","article-title":"Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis","volume":"28","author":"Vassal","year":"2000","journal-title":"Am J Infect Control"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib820","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/S1806-37132014000200004","article-title":"Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers","volume":"40","author":"Della Zuana","year":"2014","journal-title":"J Bras Pneumol"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib821","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/jcm.34.3.584-587.1996","article-title":"Home-use nebulizers: a potential primary source of burkholderia cepacia and other colistin-resistant, gram- negative bacteria in patients with cystic fibrosis","volume":"34","author":"Hutchinson","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib822","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/646697","article-title":"Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis","volume":"14","author":"Burdge","year":"1993","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib823","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcf.2015.06.004","article-title":"Fungal contamination of nebuliser devices used by people with cystic fibrosis","volume":"15","author":"Peckham","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib824","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1378\/chest.112.5.1278","article-title":"Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life","volume":"112","author":"Corden","year":"1997","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib825","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1183\/13993003\/erj.18.5.758","article-title":"GENebu Project: home nebulizer use and maintenance in Italy","volume":"18","author":"Melani","year":"2001","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib826","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0954-6111(95)90124-8","article-title":"Assessment of the continued supervision and asthma management knowledge of patients possessing home nebulizers","volume":"89","author":"Gregson","year":"1995","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib827","first-page":"1504","article-title":"Nebulizer use and maintenance by cystic fibrosis patients: a survey study","volume":"49","author":"Lester","year":"2004","journal-title":"Respir. Care."},{"key":"10.1016\/j.ijtb.2022.06.004_bib828","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pedn.2017.04.012","article-title":"The effects of smartphone-based nebulizer therapy education on parents' knowledge and confidence of performance in caring for children with respiratory disease","volume":"36","author":"Lee","year":"2017","journal-title":"Journal of pediatric nursing"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib829","doi-asserted-by":"crossref","first-page":"531A","DOI":"10.1378\/chest.1702318","article-title":"Nurses' Knowledge of Inhaler Technique in the Inpatient Hospital Setting","volume":"144","author":"DeTratto","year":"2013","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.ijtb.2022.06.004_bib830","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3109\/02770900903229701","article-title":"Inappropriate techniques used by internal medicine residents with three kinds of inhalers (a metered dose inhaler, Diskus, and Turbuhaler): changes after a single teaching session","volume":"46","author":"Kim","year":"2009","journal-title":"J Asthma"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib831","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/02770900701554334","article-title":"Inadequate skill of healthcare professionals in using asthma inhalation devices","volume":"44","author":"Self","year":"2007","journal-title":"J Asthma"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib832","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1378\/chest.123.4.1073","article-title":"Caregivers of long-term ventilator patients: physical and psychological outcomes","volume":"123","author":"Douglas","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib833","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/geront\/30.5.583","article-title":"Caregiving and the stress process: An overview of concepts and their measures","volume":"30","author":"Pearlin","year":"1990","journal-title":"The gerontologist"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib834","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1093\/geronb\/56.4.S249","article-title":"Social support and caregiver distress: a replication analysis","volume":"56","author":"Miller","year":"2001","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib835","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/nur.4770080115","article-title":"Impact of a husband's chronic illness (COPD) on the spouse's life","volume":"8","author":"Sexton","year":"1985","journal-title":"Research in nursing & health"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib836","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0036-1584792","article-title":"Control Measures for Human Respiratory Viral Infection","volume":"37","author":"Bennett","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"issue":"13","key":"10.1016\/j.ijtb.2022.06.004_bib837","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra021771","article-title":"How Contagious Are Common Respiratory Tract Infections?","volume":"348","author":"Musher","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ijtb.2022.06.004_bib838","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1164\/rccm.200912-1878CP","article-title":"Thoracic Society of Australia and New Zealand H1N1 Influenza 09 Task Force. Influenza A\/H1N1_09: Australia and New Zealand's winter of discontent","volume":"181","author":"Kotsimbos","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib948","unstructured":"CDC. History of 1918 flu pandemic. Available from https:\/\/www.cdc.gov\/flu\/pandemic-resources\/1918-commemoration\/1918-pandemic-history.htm. Accessed July 19, 2020."},{"key":"10.1016\/j.ijtb.2022.06.004_bib949","doi-asserted-by":"crossref","unstructured":"CDC. 2009 H1N1 Pandemic (H1N1pdm09 virus). Available from https:\/\/www.cdc.gov\/flu\/pandemic-resources\/2009-h1n1-pandemic.html. Accessed July 19, 2020.","DOI":"10.1097\/01.NAJ.0000360296.32464.2b"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib841","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/QCO.0000000000000563","article-title":"Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention","volume":"32","author":"Shiu","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib842","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib843","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/v11100940","article-title":"Nosocomial Transmission of Emerging Viruses via Aerosol-Generating Medical Procedures","volume":"11","author":"Judson","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ijtb.2022.06.004_bib950","unstructured":"WHO. SARS (Severe Acute Respiratory Syndrome). Available from https:\/\/www.who.int\/ith\/diseases\/sars\/en\/. Accessed July 19, 2020."},{"key":"10.1016\/j.ijtb.2022.06.004_bib951","unstructured":"CDC. Middle East Respiratory Syndrome. Available from https:\/\/www.cdc.gov\/coronavirus\/mers\/index.html. Accessed July 19, 2020."},{"issue":"382","key":"10.1016\/j.ijtb.2022.06.004_bib846","first-page":"727","article-title":"for the China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China","volume":"2020","author":"Zhu","year":"2019","journal-title":"New Engl J Med"},{"issue":"25","key":"10.1016\/j.ijtb.2022.06.004_bib847","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The severe acute respiratory syndrome","volume":"349","author":"Peiris","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib848","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.290.3.374","article-title":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome","volume":"290","author":"Lew","year":"2003","journal-title":"JAMA"},{"issue":"7477","key":"10.1016\/j.ijtb.2022.06.004_bib849","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature12711","article-title":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","volume":"503","author":"Ge","year":"2013","journal-title":"Nature"},{"issue":"9393","key":"10.1016\/j.ijtb.2022.06.004_bib850","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003","volume":"362","author":"Zhong","year":"2003","journal-title":"Lancet"},{"issue":"43","key":"10.1016\/j.ijtb.2022.06.004_bib851","first-page":"373","article-title":"WHO issues consensus document on the epidemiology of SARS","volume":"78","author":"WHO","year":"2003","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ijtb.2022.06.004_bib952","unstructured":"Middle East respiratory syndrome coronavirus (MERS-CoV) Summary of current situation, literature update and risk assessment World HealthOrganization. http:\/\/apps.who.int\/iris\/bitstream\/10665\/179184\/2\/WHO_MERS_RA_15.1_eng.pdf?ua=1. Accessed July 25, 2015."},{"issue":"16","key":"10.1016\/j.ijtb.2022.06.004_bib853","doi-asserted-by":"crossref","first-page":"20781","DOI":"10.2807\/1560-7917.ES2014.19.16.20781","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013","volume":"19","author":"Nowotny","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijtb.2022.06.004_bib953","unstructured":"COVID 19: Corona Virus Pandemic. Available from https:\/\/www.worldometers.info\/coronavirus\/Accessed May 18, 2022."},{"key":"10.1016\/j.ijtb.2022.06.004_bib954","unstructured":"American Thoracic Society. SARS-CoV-2 Transmission and the Risk of Aerosol Generating Procedures. Available fromhttps:\/\/www.thoracic.org\/patients\/patient-resources\/resources\/aerosol-generating-procedures-and-risk-of-covid-19-transmission.pdf. Accessed July 19, 2020."},{"key":"10.1016\/j.ijtb.2022.06.004_bib856","series-title":"Interface Science and Technology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1573-4285(05)80002-X","volume":"5","author":"Wang","year":"2005"},{"key":"10.1016\/j.ijtb.2022.06.004_bib857","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","article-title":"Hypothesis for potential pathogenesis of SARS-CoV-2 infection\u2013a review ofimmune changes in patients with viral pneumonia","volume":"9","author":"Lin","year":"2020","journal-title":"Emerg Microbes Infec"},{"key":"10.1016\/j.ijtb.2022.06.004_bib858","article-title":"COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020","volume":"26","author":"JianyunL","year":"2020","journal-title":"EmergInfec Dis"},{"issue":"1-2","key":"10.1016\/j.ijtb.2022.06.004_bib859","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1359-6446(05)03687-1","article-title":"Airborne infectious disease and the suppression of pulmonary bioaerosols","volume":"11","author":"Fiegel","year":"2006","journal-title":"Drug Discov Today"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib860","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0668.2006.00432.x","article-title":"Droplet fate in indoor environments, or can we prevent the spread of infection?","volume":"16","author":"Morawska","year":"2006","journal-title":"Indoor Air"},{"key":"10.1016\/j.ijtb.2022.06.004_bib861","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2009.0302.focus","article-title":"Aerosol transmission of influenza A virus: a review of new studies","author":"Tellier","year":"2009","journal-title":"J R Soc Interface"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib862","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0668.2007.00469.x","article-title":"How far droplets can move in indoor environments\u2013revisiting the Wells evaporation-falling curve","volume":"17","author":"Xie","year":"2007","journal-title":"Indoor Air"},{"key":"10.1016\/j.ijtb.2022.06.004_bib863","article-title":"Droplets, and Airborne Spread: Everything you could possibly want to know","author":"Morgenstern Aerosols","year":"2020","journal-title":"First 10EM"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib864","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/15459620590918466","article-title":"Toward understanding the risk of secondary airborne infection: emission of respirable pathogens","volume":"2","author":"Nicas","year":"2005","journal-title":"J Occup Environ Hyg"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib865","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0668.2009.00626.x","article-title":"Some questions on dispersion of human exhaled droplets in ventilation room: answers from numerical investigation","volume":"20","author":"Chen","year":"2010","journal-title":"Indoor Air"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib866","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/jam.1997.10.105","article-title":"The size distribution of droplets in the exhaled breath of healthy human subjects","volume":"10","author":"Papineni","year":"1997","journal-title":"J Aerosol Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib867","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/MMBR.00002-08","article-title":"Methods for sampling of airborne viruses","volume":"72","author":"Verreault","year":"2008","journal-title":"Microbiol Mol Biol Rev."},{"key":"10.1016\/j.ijtb.2022.06.004_bib868","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4756","article-title":"Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19","author":"Bourouiba","year":"2020","journal-title":"JAMA"},{"issue":"46","key":"10.1016\/j.ijtb.2022.06.004_bib869","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3310\/hta14460-02","article-title":"Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections","volume":"14","author":"Simonds","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ijtb.2022.06.004_bib870","volume":"13","author":"Rule","year":"2018"},{"key":"10.1016\/j.ijtb.2022.06.004_bib871","article-title":"Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1","author":"Doremalen","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib872","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.12458","article-title":"Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence","author":"Klompas","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijtb.2022.06.004_bib873","series-title":"Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations","author":"Scientific brief","year":"2020"},{"issue":"12","key":"10.1016\/j.ijtb.2022.06.004_bib874","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1086\/502353","article-title":"A large-volume nebulizer would not be an infectious source for severe acute respiratory syndrome","volume":"25","author":"Wan","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib875","series-title":"Transmission of SARS-CoV-2: implications for infection prevention precautions World Health Organization Published on9","author":"Scientific Brief","year":"2020"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib876","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3201\/eid1002.030452","article-title":"Cluster of SARS among medical students exposed to single patient","volume":"10","author":"Wong","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib877","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2458-9-81","article-title":"Which preventive measures might protect health care workers from SARS?","volume":"9","author":"Chen","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijtb.2022.06.004_bib878","series-title":"Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center","author":"Santarpia","year":"2020"},{"key":"10.1016\/j.ijtb.2022.06.004_bib879","series-title":"Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak","author":"Liu","year":"2020"},{"key":"10.1016\/j.ijtb.2022.06.004_bib880","series-title":"Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China","author":"Guo","year":"2020"},{"key":"10.1016\/j.ijtb.2022.06.004_bib881","doi-asserted-by":"crossref","DOI":"10.3201\/eid2609.201806","article-title":"Persistence of severe acute respiratory syndrome coronavirus 2 in aerosol suspensions","author":"Fears","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib882","series-title":"Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic (April 1, 2020)","author":"Fineberg","year":"2020"},{"key":"10.1016\/j.ijtb.2022.06.004_bib883","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jhin.2006.05.022","article-title":"Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises","volume":"64","author":"Tang","year":"2006","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijtb.2022.06.004_bib884","article-title":"Prevention and Control of Influenza during a Pandemic for All Healthcare Settings","author":"Public Health Agency of Canada","year":"2011","journal-title":"Annex F"},{"key":"10.1016\/j.ijtb.2022.06.004_bib885","article-title":"Coronavirus disease 2019 (COVID-19) Healthcare infection prevention and control FAQs for COVID-19","author":"Centers for Disease Control and Prevention","year":"2020","journal-title":"Updated"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib886","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/resp.13558","article-title":"Emerging respiratory infections threatening public health in the Asia-Pacific region: A position paper of the Asian Pacific Society of Respirology","volume":"24","author":"Park","year":"2019","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib887","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035797","article-title":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review","volume":"7","author":"Tran","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib888","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1164\/rccm.200305-715OC","article-title":"Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation","volume":"169","author":"Fowler","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib889","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3201\/eid1002.030700","article-title":"SARS Investigation Team. Possible SARS coronavirus transmission during cardiopulmonary resuscitation","volume":"10","author":"Christian","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib890","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/0194599820927335","article-title":"High-Risk Aerosol-Generating Procedures in COVID-19: Respiratory Protective Equipment Considerations","volume":"163","author":"Howard","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijtb.2022.06.004_bib891","series-title":"Pandemic (H1N1) 2009 influenza. A summary of guidance for infection control in healthcare settings","author":"Department of Health and Health Protection Agency","year":"2009"},{"key":"10.1016\/j.ijtb.2022.06.004_bib892","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa030685","article-title":"A major outbreak of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib893","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3201\/eid1002.030645","article-title":"Index patient and SARS outbreak in Hong Kong","volume":"10","author":"Wong","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib894","series-title":"Prevention and control of influenza during a pandemic for all healthcare settings","year":"2011"},{"issue":"1","key":"10.1016\/j.ijtb.2022.06.004_bib895","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/ijaai.ijaai_29_20","article-title":"Nebulization in the pandemic of Coronavirus disease 2019","volume":"34","author":"Katiyar","year":"2020","journal-title":"Ind. J. Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib896","doi-asserted-by":"crossref","first-page":"e10717","DOI":"10.1371\/journal.pone.0010717","article-title":"Risk Factors for SARS Transmission from Patients Requiring Intubation: A Multicentre Investigation in Toronto,","volume":"5","author":"Raboud","year":"2010","journal-title":"CanadaPLoS One"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib897","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3201\/eid1002.030838","article-title":"SARS among Critical Care Nurses","volume":"10","author":"Loeb","year":"2004","journal-title":"TorontoEmerg Infect Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib898","series-title":"Guide to Aerosol Delivery Devices for Physicians, Nurses, Pharmacists, and Other Health Care Professionals American Association for Respiratory Care","first-page":"17","author":"Gregory","year":"2013"},{"key":"10.1016\/j.ijtb.2022.06.004_bib899","first-page":"105987","article-title":"A Guide to Aerosol Delivery Devices for Respiratory Therapists","volume":"167","author":"Gardenhire","year":"2020"},{"key":"10.1016\/j.ijtb.2022.06.004_bib900","doi-asserted-by":"crossref","first-page":"105987","DOI":"10.1016\/j.rmed.2020.105987","article-title":"Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19","volume":"167","author":"Ari A","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib955","unstructured":"GOV.UK: COVID-19: infection prevention and control (IPC) (https:\/\/www.gov.uk\/government\/publications\/wuhan-novel-coronavirus-infectionprevention-and-control)."},{"key":"10.1016\/j.ijtb.2022.06.004_bib956","unstructured":"National Institute for Health and Care Excellence. COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD). Published April 9, 2020. Available from https:\/\/Www.Nice.Org.Uk\/Guidance\/Ng168\/Resources\/Covid19-Rapid-Guideline-Communitybased-Care-Of-Patients-With-Chronic-Obstructive-Pulmonary-Disease-Copd-Pdf-66141907467973.Accessed July 19, 2020."},{"key":"10.1016\/j.ijtb.2022.06.004_bib957","unstructured":"United Kingdom Government. New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). Available from https:\/\/Www.Gov.Uk\/Government\/Publications\/Wuhan-Novel-Coronavirus-Infection-Prevention-And-Control\/Covid-19-Personal-Protective-Equipment-Ppe.Accessed July 19, 2020."},{"key":"10.1016\/j.ijtb.2022.06.004_bib904","series-title":"Clinical management of COVID-19","year":"2020"},{"issue":"15","key":"10.1016\/j.ijtb.2022.06.004_bib905","doi-asserted-by":"crossref","first-page":"472","DOI":"10.15585\/mmwr.mm6915e5","article-title":"Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient - Solano County, California, February 2020","volume":"69","author":"Heinzerling","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijtb.2022.06.004_bib906","author":"Minnesota Department of Health"},{"key":"10.1016\/j.ijtb.2022.06.004_bib958","unstructured":"COPD Foundation. Webinar: COVID-19, COPD and you: important strategies from leading medical experts on managing your health. Available from https:\/\/Www.Copdfoundation.Org\/Downloads\/Covid19_Webinar_Q_&_A_Final.Pdf. Accessed July 19, 2020."},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib908","first-page":"136","article-title":"Nebulized treatments and the possible risk of coronoavirus transmission: where is the evidence?","volume":"7","author":"Tashkin","year":"2020","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib909","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ageing\/26.2.83","article-title":"Competence thresholds for the use of inhalers in people with dementia","volume":"26","author":"Allen","year":"1997","journal-title":"Age Ageing"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib910","first-page":"1182","article-title":"Inhaler technique of outpatients in the home","volume":"45","author":"Johnson","year":"2000","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib911","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4140\/TCP.n.2015.92","article-title":"Inhaler misuse in an older adult population","volume":"30","author":"Vanderman","year":"2015","journal-title":"Consult Pharm"},{"key":"10.1016\/j.ijtb.2022.06.004_bib912","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan","author":"Wang","year":"2020","journal-title":"China. J. Am. Med. Assoc"},{"key":"10.1016\/j.ijtb.2022.06.004_bib913","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib915","first-page":"E02","article-title":"Chinese Medical Association Respiratory Branch Expert consensus on protective measures related to respiratory therapy in patients with severe and critical coronavirus infection","volume":"17","year":"2020","journal-title":"Chin. J. Tuberc. Respir. Dis"},{"key":"10.1016\/j.ijtb.2022.06.004_bib916","first-page":"845","article-title":"Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation","volume":"55","author":"Ari","year":"2010","journal-title":"Respir. Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib917","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4187\/respcare.03790","article-title":"Aerosol therapy in pulmonary critical care","volume":"60","author":"Ari","year":"2015","journal-title":"Respir. Care"},{"key":"10.1016\/j.ijtb.2022.06.004_bib918","doi-asserted-by":"crossref","first-page":"677","DOI":"10.5005\/jp-journals-11010-05103","article-title":"Secondhand aerosol exposure during mechanical ventilation with and without expiratory filters: an in-vitro study","volume":"5","author":"Ari","year":"2016","journal-title":"Ind J. Respir. Care"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib919","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/jam.2006.19.385","article-title":"Assessing a system to capture stray aerosol during inhalation of nebulized liposomal cisplatin","volume":"19","author":"Wittgen","year":"2006","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib920","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4187\/respcare.06085","article-title":"The effect of different closed suction catheter designs and pMDI adapters on aerosol delivery in simulated adult mechanical ventilation with and without exhaled humidity","volume":"63","author":"Williams","year":"2018","journal-title":"Respir. Care"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib921","doi-asserted-by":"crossref","first-page":"880","DOI":"10.4187\/respcare.04042","article-title":"Aerosol Therapy During Noninvasive Ventilation or High-Flow Nasal Cannula","volume":"60","author":"Hess","year":"2015","journal-title":"Respiratory care"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib922","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4187\/respcare.01371","article-title":"Noninvasive ventilation coupled with nebulization during asthma crises: a randomized controlled trial","volume":"58","author":"Galindo-Filho","year":"2013","journal-title":"Respiratory care"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib923","first-page":"1331","article-title":"Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients","volume":"50","author":"Dhand","year":"2005","journal-title":"Respir Care"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib924","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.2042-7158.2010.01134.x","article-title":"In-vitro characterisation of the nebulised dose during non-invasive ventilation","volume":"62","author":"Abdelrahim","year":"2010","journal-title":"The Journal of pharmacy and pharmacology"},{"issue":"11","key":"10.1016\/j.ijtb.2022.06.004_bib925","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1097\/00003246-200211000-00018","article-title":"In\u00a0vitro evaluation of aerosol bronchodilator delivery during noninvasive positive pressure ventilation: effect of ventilator settings and nebulizer position","volume":"30","author":"Chatmongkolchart","year":"2002","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib926","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1378\/chest.130.3.730","article-title":"Noninvasive positive-pressure ventilation: an experimental model to assess air and particle dispersion","volume":"130","author":"Hui","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib927","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1183\/09031936.00052208","article-title":"Noninvasive ventilation and the potential risk of transmission of infection","volume":"32","author":"Singh","year":"2008","journal-title":"Eur RespirJ"},{"key":"10.1016\/j.ijtb.2022.06.004_bib928","first-page":"M20","article-title":"Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19. A Living Systematic Review of Multiple Streams of Evidence","author":"Sch\u00fcnemann","year":"2020","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.ijtb.2022.06.004_bib929","doi-asserted-by":"crossref","first-page":"472","DOI":"10.5694\/mja2.50598","article-title":"Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group","volume":"212","author":"Brewster","year":"2020","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.ijtb.2022.06.004_bib930","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1016\/S2213-2600(20)30181-8","article-title":"Use of non-invasive ventilation for patients with COVID-19: a cause for concern?","volume":"8","author":"Arulkumaran","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.ijtb.2022.06.004_bib931","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1378\/chest.14-1934","article-title":"Exhaled air dispersion during noninvasive ventilation via helmets and a total facemask","volume":"147","author":"Hui","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2022.06.004_bib932","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhin.2018.10.007","article-title":"Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial","volume":"101","author":"Leung","year":"2019","journal-title":"J. Hosp. Infect"},{"key":"10.1016\/j.ijtb.2022.06.004_bib933","series-title":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidanceInterim guidance","year":"2020"},{"key":"10.1016\/j.ijtb.2022.06.004_bib934","author":"ANZICS COVID-19 Working Group"},{"key":"10.1016\/j.ijtb.2022.06.004_bib959","unstructured":"Alhazzani W, M\u00f8ller MH, Arabi YM, et\u00a0al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). www.esicm.org\/wp-content\/uploads\/2020\/03\/SSC-COVID19-GUIDELINES.pdf (accessed 25\/03\/2020).."},{"issue":"7","key":"10.1016\/j.ijtb.2022.06.004_bib936","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/anae.15073","article-title":"The use of high-flow nasal oxygen in COVID -19","volume":"75","author":"Lyons","year":"2020","journal-title":"Anaesthesia"},{"issue":"4","key":"10.1016\/j.ijtb.2022.06.004_bib937","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4187\/respcare.06345","article-title":"Aerosol Delivery Through an Adult High-Flow Nasal Cannula Circuit Using Low-Flow Oxygen","volume":"64","author":"\u2013 Madney","year":"2019","journal-title":"Respir Care"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib938","doi-asserted-by":"crossref","first-page":"2000892","DOI":"10.1183\/13993003.00892-2020","article-title":"High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion","volume":"55","author":"Li","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2022.06.004_bib939","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany","author":"Rothe","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ijtb.2022.06.004_bib940","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2213-2600(20)30270-8","article-title":"Use of aerosolised medications at home for COVID-19","volume":"8","author":"Ari","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib941","doi-asserted-by":"crossref","DOI":"10.31646\/gbio.64","article-title":"Disinfection measures and control of SARS-COV-2 transmission","volume":"1","author":"Duarte","year":"2020","journal-title":"Global Biosecurity"},{"issue":"2","key":"10.1016\/j.ijtb.2022.06.004_bib942","doi-asserted-by":"crossref","first-page":"100044","DOI":"10.1016\/j.infpip.2020.100044","article-title":"Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents","volume":"2","author":"G\u00fcnterKampf","year":"2020","journal-title":"Infection Prevention in Practice"},{"issue":"3","key":"10.1016\/j.ijtb.2022.06.004_bib943","first-page":"246","article-title":"Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation","volume":"16","author":"Duan","year":"2003","journal-title":"Biomedical and Environmental Sciences"},{"issue":"5","key":"10.1016\/j.ijtb.2022.06.004_bib944","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1017\/ice.2015.348","article-title":"Efficacy of an Automated Multiple Emitter Whole-Room Ultraviolet-C Disinfection System Against Coronaviruses MHV and MERS-CoV","volume":"37","author":"Bedell","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijtb.2022.06.004_bib945","article-title":"ATS Patient Education Series American Thoracic Society. Nebulizer breathing treatments at home","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2022.06.004_bib946","article-title":"Interim Recommendations for U.S. Community Facilities with Suspected\/Confirmed Coronavirus Disease 2019 (COVID-19)","author":"Cleaning and Disinfection for Community Facilities","year":"2020","journal-title":"Centres for Disease Control and Prevention US"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570722000993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570722000993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:02:04Z","timestamp":1758081724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570722000993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":944,"alternative-id":["S0019570722000993"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2022.06.004","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indian Guidelines on Nebulization Therapy","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2022.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}